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This annual report covers the activities of the New England Genetics Collaborative (NEGC) from June 1, 
2010 to May 31, 2011. The purpose of this report is to provide the reader with additional documentation on 
the utilization of grant funds and what has been achieved as a result, to provide an overview of NEGC 
activities for both old and new partners, and to offer recommendations for the collaborative's improvement 
and ultimate achievement of its mission and vision.  
Mission: The mission of the NEGC is to promote and improve the health and social well-being of those with inherited 
conditions through collaborations among public health professionals, private health 
professionals, educators, consumers and advocates in Maine (ME), New Hampshire (NH), Vermont 
(VT), Massachusetts (MA), Rhode Island (RI) and Connecticut (CT). 
Vision: All individuals with genetic conditions living in New England have the opportunity to achieve their fullest 
potential. 
This report includes: a summary of activities by the Regional Coordinating Council (RCC), Workgroups, and 
Evaluation Staff during the period; primary findings of the project’s fourth stakeholder survey; an update on 
the status of core project components from Year Four; a list of objectives for each group for Year Five; and 
recommendations to the project by the project evaluator. The material provided in this report is based on 
information submitted to evaluation staff as of Oct. 1, 2011. Members of the Collaborative Council were 
provided an opportunity to review and comment on the enclosed material. Evaluation of the project is led by 
Peter Antal, Ph.D., Institute on Disability, UNH. 
The current New England Regional Genetics and Newborn Screening Collaborative (NEGC) grant (HRSA 
Grant # U22MC10980) officially began June 1, 2007. During its fourth year of activity, core project staff have 
continued to focus on improving the infrastructure of the NEGC (launching the new website, improving the 
RFP process, and structural improvements to the organization) and increasing support to coalition members. 
Together with the Workgroups, they have been meeting and carrying out the work of the NEGC through a 
broad range of collaborative activities, including a special focus on metabolic centers workforce capacity and 
launching New England's first Emergency Preparedness symposium. The Quality Improvement Workgroup 
completed business associate agreements with centers in Maine and New Hampshire with Vermont’s in 
process to support quality improvement activities and successfully launched a new learning collaborative with 
8 participating metabolic centers representing all NE states. The Transition Workgroup continued to build on 
both regional and national level activities, implementation of a new Teen Challenge Program, disseminating 
the Transition Toolkit, and collaborating with national partners. The Medical Home Workgroup pursued the 
development of a new survey needs assessment to document care, coordination and communication practices 
among primary care providers, specialists and families. The Dissemination, Education, and Marketing 
Workgroup developed the framework and background material for the new GEMSS website for special 
educators to improve support for students with genetic conditions. The Laboratory Quality Assurance 
Workgroup conducted analyses and compared results to follow-up for: 3MCC, BKT, GA-I, MSUD, CIT-I, 
and ASA, with a presentation to the Laboratory Subcommittee of the SACHDNC. Lastly, the Long-Term 
Follow-up Workgroup achieved a major accomplishment by solidifying an agreement with legal 
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representatives from Rhode Island which allows for the collection of LTFU data. Additionally, they held a 
national conference on improvement of long-term outcomes for individuals with Sickle Cell Disease.  
Concerning stakeholder satisfaction with the progress of the NEGC, findings from the recently completed 
stakeholder survey showed multiple improvements over the previous year. A majority of respondents (N=63) 
understood the mission of the NEGC (73%) and felt that the NEGC has made clear and substantive progress 
in achieving its mission (72%). In reviewing the goals and objectives for Year Four, 96% of 54 objectives 
have either been completed (63%) or have made satisfactory progress (33%) in accordance with the long term 
goals of the grant. Objectives for Year Five have been shared and agreed to by project staff and chairs of the 
project’s work groups. In preparing to successfully meet the collaborative's objectives, a range of challenges 
and recommendations for improvement have been identified in the final section of this report. 
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COALITION CHANGES AND IMPROVEMENTS 
Organizational Overview 
The Regional Coordinating Center (RCC) is staffed by John Moeschler, MD and Monica McClain, Ph.D., 
who serve as Principle Investigators, Ms. Karen Smith as Project Coordinator, Kit McCormick as Project 
Staff, and Peter Antal, Ph.D. as Project Evaluator. Administrative support is provided by the UNH Institute 
on Disability, which acts as fiscal agent. 
In 2010 – 2011, the RCC carried out substantial portions of its work through six Workgroups: Quality 
Improvement, Medical Home, Transition, Laboratory Quality Assurance, Long Term Follow-Up, and 
Dissemination, Education and Marketing. The chair of each Workgroup is a member of the Collaborative 
Council; the Council meets three times a year to facilitate coordination of Workgroup activities. The RCC and 
Collaborative Council are guided by an Advisory Committee which meets annually to help set direction for 
the collaborative and to provide feedback / raise issues throughout the year as needed.  Lastly, a Review 
Committee is formed annually to provide review and guidance on funding requests from the collaborative's 
innovative projects program. Please see Appendix A for the current organizational chart. 
Organizational Improvements 
During Year 4, the NEGC staff focused on strengthening its communication strategies and supporting 
sustainability efforts for genetic services region wide. 
Implementing the Communication Plan 
During the course of the project year, project staff launched a new e-newsletter describing NEGC activities 
and important updates for partners and made a range of enhancements to the project's website 
(www.negenetics.org). Enhancements were made in the following areas:  
• Structural 
o New site launched in December, 2010 
o Expanded list format for presenting information 
o Improved access to information for families and professionals 
o Added join our mailing list option, twitter link 
o Improved access to products and publications 
o Enabled password protection for joint team review of grant applications for innovative 
projects 
• Information 
o Added more state resource information 
o Provided updates to Did You Know and Featured Resource allowing for easier highlighting of 
key activities 
o Extracted glossary of terms and made accessible on website 
• Design 
o Updated graphics throughout to reflect diversity 







































Fig. 1 NEGC Unique Users and Visits




Between November 2010 and May 2011, there were 962 unique visitors to the NEGC website and 2,349 
visits. Over the course of these 7 months, the number of users and visits gradually increased, the average time 
spent on the website increased from 3:52 to 5:31 minutes, and the average number of page views increased 











As the NEGC grows it will be helpful to track how the NEGC is doing relative to its outreach efforts and to 
identify what kinds of outreach works best. In looking across different referral sources to the website and the 
levels of activity generated (See Table 1), the most effective source was direct web links provided to 
stakeholders, with 77 visits generated and an average time of 6:58 minutes per visit, followed by referrals from 
partner organizations which generated 337 visits and an average time of 4:23 minutes. Of note, links driven by 
social media (Tumblr, Facebook, Twitter) accounted for 200 visits, an average time of 0:55 minutes on the 
website and a bounce rate of 89%. Other refers primarily to web market generated referrals from PRweb.com 
and other unaffiliated sites. 
  
                                                          
1
 The reader should note that these numbers are lower than previous years due to the fact that a completely different 
tracking system was used in conjunction with the new website.  The new program, run through Google Analytics, provides a 
more accurate and detailed view of NEGC website users.  Given the substantive changes, the numbers presented this year are 
not comparable with data from the previous year. 
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Sources of Referral to the NEGC Website 
Table 1: Referring Sources to the NEGC Website 
Source Visits Pages/Visit 
Avg 





Direct Link 777 6.6 0:06:58 28.7% 36.4% 
Partner Org 337 4.6 0:04:23 35.0% 38.9% 
Email Referral 23 4.2 0:01:41 47.8% 52.2% 
Search 871 2.7 0:01:40 66.1% 55.5% 
Social 200 1.6 0:00:55 2.5% 89.0% 
Other 54 1.6 0:01:25 3.7% 50.0% 
 
Outside of the IOD, the top five organizational drivers to the NEGC website was the NCC (88), NBS 
Clearinghouse (22), MCH LEND (21), CDC (19), and the New England Consortium of Metabolic 
Programs(11).  A total of 21 organizations were identified as referral sources to the NEGC. 
National Outreach of the NEGC 
Of the 2,165 visitors to the NEGC website, about half were from New Hampshire (995)3. States with 50 or 
more visitors include: Massachusetts (277), Georgia (96), Connecticut (96), Vermont (88), New York (61), 
Maine (60), and California (51); please see Fig.1. 
  
                                                           
2
 Bounce rate refers to percentage of initial visitors to a site who "bounce" away to a different site, rather than continue on to 
other pages within the same site 
3
 However, 604 visits (61%) of the NH traffic were generated from the city of Durham (where the administrative staff of the 
NEGC resides).   
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Figure 1: Distribution of NEGC Website Traffic by State 
 
Resource Leveraging  
During Year Four, NEGC staff submitted one grant application to support new or expanded work in genetics 
in the New England region.  This application was not funded. The NEGC provided 5 letters of support for 
five projects, two of which were funded. 
Table 2: Applications and Letters of Support 
Direct Applications 
Grant Name Description Amount 
Natural History of Disorders 
Identifiable by NBS 
Project Yr 4. NIH. NOT FUNDED 
Letters of Support for Partner Applications 
Grant Name Description Amount 
Genetics in Primary Care Institute Project Yr 4. American Academy 
of Pediatrics. Create a community 
of learners to enhance primary 
care provider ability to provide 
genetic related services, address 
Funded. 
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systems and policy supports to 
accelerate provision of genetic 
medicine, assess residency training 
curriculum for genetic medicine. 
Family to Family Health 
Information Center 
Project Year 4. Federation for 
Children with Special Needs. 
Funded. 
NBSTRN Project Year 4. American College 
of Medical Genetics. Build an 
electronic data capture tool for 
long term follow up of children 
identified by newborn screening. 
Letter written to support need for 
this activity. 
Noonan Foundation Project Year 4. Children’s Hospital 
Boston. For follow up meetings of 
the Face Forward Program. 
Not funded. 
The Parent-Child Relationship and 
Newborn Screening: Preserving 
the Ties that Bind 
Project Year 4. Assess whether the 
parent-child relationship is 
disrupted in parents whose infant 
receives an initial out-of-range 
newborn metabolic screening 
result and whether uncertainty 
surrounding the result is 
associated with reduced self-
reported ratings of bonding for 
both mothers and fathers. 
Not funded. 
 
For a complete list of resources leveraged to date, please see Appendix B. 
New Committee Launched - Advocacy Committee  
As a result of feedback gathered from the 2010 Annual Meeting, the NEGC brought together 13 individuals 
representing all New England states, as well as a range of professional and family interests. The group 
brainstormed a range of project ideas with the result of focusing directly on the concept of essential benefits 
under health care reform. Through a partnership with NH Family Voices, an application was developed and 
submitted to the NEGC Innovative Projects program. Although the effort was not funded, the group 
anticipates continuing to work on this area during Year 5 of the project as well as providing feedback to the 
NEGC on how it can best meet the needs of individuals and families. 
Collaborative Activities 
Project staff continued to seek out new opportunities for partnerships with both regional and national 
partners. During Year Four, this included: joint planning of the annual meeting with NERGG, 11 
presentations and 5 publications by affiliated staff, 10 training/technical assistance activities, 4 newly funded 
innovative projects, 3 applications supported through the community and family network grants, special 
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projects supporting the mission of the NEGC, and continuing collaborations with regional and national 
partners. The following outlines each of these accomplishments in more detail. 
Annual Meeting, Dec. 1, 2010 
The annual meeting was well attended by 65 partners in the initiative, representing an increase of 19 
participants over the previous year. Project staff highlighted the key accomplishments of the project over the 
course of the past year and identified major activities to be undertaken for next year. Breakout sessions on 
how to effectively engage with genetic counselors, families, and the New England Birth Defects Consortium 
were held. In addition, open workgroup meetings were held that enabled cross group and new stakeholder 
participation in the activities of individual workgroups.    
Most participants found the meeting helpful, that they had opportunities to share their perspectives, that they 
had a good understanding of what the NEGC will accomplish in Year 5, and that the NEGC is “headed in 
the right direction.”  More than half of responding participants felt that the work of the NEGC resulted in 
tangible outcomes resulting in improvements in high quality genetic services in the region. In terms of 
recommendations, participants highlighted a range of groups to which the NEGC staff could do additional 
outreach, including major medical centers, school nurses, family advocate groups, March of Dimes, Save our 
Babies, Medicaid leadership and other major organizations (AAP, AFP, ACM, CCPCMH).  A copy of the full 
meeting 'mid-year' report is available at http://www.negenetics.org/AboutUs/Evaluation_reports.aspx. 
Presentations and Publications Supported by the NEGC 
During Project Year Four, NEGC coalition stakeholders conducted 12 presentations about project activities. 
This included an update on Long Term Follow Up (LTFU) activities in New England to the National 
Coordinating Center / Regional Center Annual Meeting as well as a short course on CF NBS and Care 
Quality Improvement at the the 2010 North American Cystic Fibrosis Conference. Both sessions were 
conducted by Dr. Anne Comeau. A third presentation was by Dr. Susan Waisbren during a conference on  
neurocognitive issues in PKU and transition to adult care.  For a detailed listing of presentations and 
presenters to date, please see Appendix C.  
By the end of Project Year Four, 5 additional publications were created by NEGC collaborative council 
members, bringing the total publications list of NEGC stakeholders up to 204. The most recent publications 
include: 
 McGrath RJ, Stransky ML, Cooley WC, Moeschler JB. National profile of children with Down Syndrome: 
disease burden, access to care, and family impact. J Pediatr. 2011; in press.    
 Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, Phornphutkul C. Congenital hypothyroidism 
with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental 
outcomes. J Pediatr. 2011;158(4):538-42. 
 Sahai I, Eaton RB, Hale JE, Mulcahy EA, Comeau AM. Long-term follow-up to ensure quality care of 
individuals diagnosed with newborn screening conditions: early experience in New England. Genet Med. 2010;12(12 
Suppl):S220-7. 
                                                           
4
 The number of total publications has been reduced from last year due to updated definitions from national partners as to 
what constitutes an NEGC supported publication. 
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 Hale JE, Parad RB, Dorkin HL, Gerstie R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM. 
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis. 
2010;33(Suppl 2):S255-61. 
 Fanos JH, Wiener L, Brennan T. Potential impact of genomic information on childhood sibling relationships. In: 
Handbook of genomics and the family, Issues in clinical child psychology, K.P. Tercyak (ed.), Springer 
Science, 141-61, 2010. 
 
For a detailed listing of publications supported by the collaborative and its members, please see Appendix D. 
Trainings and Technical Assistance  
Through its many collaborators and supporters, staff funded by the NEGC carried out a range of training and 
technical assistance activities to families, consumers of health services, health providers, education providers, 
state staff, community organizations, and others. Of the 3,309 aided in this manner, an estimated 3,000 
individual contacts were made by the Birth Defects Consortium in its effort to improve understanding and 
utilization of folic acid during pregnancy. Additional areas of focus touched on: support around Down 
syndrome education, emergency preparedness, support for grant applications and conducting research, 
training professionals on assessment tools and transition practices, training staff on the use of learning 
collaboratives, database utilization for improving care, and the legal aspects of data use. 
Innovative Projects 
The RCC continued to build on the innovative projects program and completed its fourth round of grant 
funding. The NEGC received 10 proposals and awarded four grants, with a combined total disbursement of 
$86,985. The studies funded by these grants include:   
• "Exploring and identifying the knowledge level and attitudes of (selected) diverse 
populations toward genetics and genetic services," submitted by Patricia Rissmiller of Simmons 
College. Awarded: $12,500. 
 
Four focus groups were held to gain an understanding of how select diverse populations think about 
and discuss genetics and genetic services. One focus group involved 15 members of the Haitian 
Community Group and three groups were held at the Somalian development center, with 7-10 
women participating in each group. Initial review indicates that, although participants had limited if 
any knowledge of the topic, they were eager to learn more. Next steps for this effort are to complete 
the analysis of the focus groups and to consult with the organizations to identify the most culturally 
relevant strategy to educate the community about genetics and genetic services. If successful, a long 
term goal will be to launch this effort on a broader scale via a community based participatory research 
grant. 
 
• "Implementation of the New England Birth Defects Consortium - Year 2", submitted by 
Stephanie Miller of Dartmouth Medical School. Awarded: $30,000. 
 
In addition to formalizing the Consortium via regular meetings and membership development, the 
Consortium collaborated with the Women, Infants, and Children departments in each of the six New 
England states to launch a multi-vitamin distribution campaign. As a part of this effort, the 
Consortium is conducting a pre and post survey study (ending 12/31/11) that will document the 
utility of a multi-vitamin distribution campaign to improve knowledge of folic acid use among 
 10 
women. A second major effort of the group this year focused on determining the utility of combining 
data for 12 birth defects across participating states. Data for this effort was collected from Maine, 
Connecticut, Rhode Island and New Hampshire, with Vermont sending data in 2011. The NEBDC 
notes that it had a successful second year and plans to work together and maintain the integrity of the 
group in the future. It looks forward to working with the NEGC on future activities as needed.  
 
• "Integrative Community-Based Management for Adults with Sickle Cell Disease," submitted 
by Victoria Odesina of UConn Health Center. Awarded: $15,000. 
 
Two home care agencies (Masonicare Partners Home Health & Hospice and the VNA of South-
Central Connecticut) were successfully recruited and became active participants in a multi-agency 
effort to provide integrated community based care for adults with sickle cell. Participants received 
educational information on integrative care models, clinical research ethics, and participatory research. 
During this first year of the project, partners identified a list of home health care needs for adults with 
SCD. Additionally, home care agencies received information on the services that would and would 
not be covered by insurance companies as well as the fees for other services that may be needed but 
not covered for this population. The group created an MOU and outlined a series of objectives for 
project year two which outlines the working relationship among partner organizations including their 
roles and responsibilities as part of their involvement in the Collaboration of Care for Adults Living 
with Sickle Cell Disease. The overall goal of the collaboration will be to improve the home health care 
and quality of life for adults with SCD with a specific focus on: appraising home services needs of 
adults with SCD, facilitating home care management prescriptions for clients and providers, 
demonstrating a seamless sharing of client health information concerning acute, chronic care and 
coordination needs, maintaining or increasing community social supports and providing prevention 
and health education services for improving functional status and health related quality of life 
indicators, and examining the cost effectiveness of home health care on ER visits, day treatment or 
inpatient care. 
 
• "Increasing Access to Care for Newborn-Screened Children with Fatty Acid Oxidation 
Disorders," submitted by Dr. Susan Waisbren of Children's Hospital, Boston. Awarded: $29,485. 
 
Dr. Waisbren focused on improving access to psychological and developmental evaluations for 
patients with fatty acid oxidation disorders (FAODs) and to improve education about the 
developmental and psychological issues in FAODs.  
 
The project identified 41 patients with FAODs and focused on conducting 21 interviews with parents 
of children with MCADD. In addition to in-person interviews, parents completed questionnaires 
assessing overall functioning, emotional well being, and executive functioning. Four families of older 
children were contacted to assess school outcomes and medical records were reviewed on an 
additional 20 children with other FAODs to examine results from the parent questionnaires and 
developmental and neuropsychological testing. 
 
Of note, the study's results suggest that children with FAODs may have emotional and learning issues 
that have not previously been recognized by assessments such as the Bayley Scales of Infant 
Development or tests of intelligence. Forty-four percent of children in the study had scores in the at-
risk range on withdrawal scales and 33% had scores in the at-risk range on anxiety scales from the 
Behavioral Assessment System for Children. The potential implications of these factors were 
discussed particularly as they related to energy depletion and school and the decreased likelihood of 
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youth seeking out and obtaining needed nutrients throughout the day. It was also noted that teachers 
may not be aware of the disorder or understand the symptoms that children may experience. 
 
In response to these findings, the project developed the MCADD Educator's Guide to help teachers 
better understand the disorder and prevent problems related to an FAOD from occurring. The Guide 
will be posted online at: http://newenglandconsortium.org and at www.negenetics.org. In addition, 
the guide will be featured on the GEMSS website, developed by the DEM workgroup, upon its 
completion. 
 
For final reports submitted by each of the above grant recipients, please visit the NEGC website at: 
http://www.negenetics.org/innovative.html.  
Community and Family Network (CFN) Grants 
During 2010, community and family level innovation and participation in genetic services was supported by 
three CFN grants.  Five applications were submitted and three were approved. The awardees include:  
• National Tay-Sachs & Allied Diseases Association (NTSAD). $2,500 was provided to support the 
development of a new web site (www.ntsad.org), increasing access to comprehensive information for 
families & members, which would in turn increase donations and support for the organization.  
• Maine Down Syndrome Network: $2,500 was provided to help cover costs of presenters at their 
annual conference in November 2010. Presenters included: Susan Shapiro (“Friendship for all Kids: 
What to Do and What to Undo”), D. Kelley Young (“Estate Planning: Thoughts and Concerns for 
Parents”), and Dr. David Stein (“Behavioral Problems and Behavioral Interventions In Children with 
Down Syndrome”). 
• Alzheimer’s Association, CT Chapter: $2,460 provided to support the keynote speaker (Dr. Robert 
Green) on the genetics of Alzheimer’s Disease, at their annual conference in November 2010. 
 
Special Projects 
Throughout the year, the NEGC engaged in several unique projects to improve the field of genetics 
education and services. During Year Four, the NEGC supported work in the following areas: assessing 
genetic workforce capacity, reviewing emergency preparedness protocols in New England, and clarifying state 
rules for information use around newborn screening. 
Assessing Genetic Workforce Capacity 
Led by Robert McGrath, Ph.D. from UNH and in partnership with the American College of Medical 
Genetics, this project reviewed the newborn screening process in five New England states and held a series of 
key informant interviews to document care processes for selected patients. Much of the focus of this work 
was on understanding the complexities that can hinder the care process as well as the strategies adopted to 
address these barriers. As a result, the project documented that the newborn screening processes, while 
different for each state, appeared to work well. In taking a close look at the care process following newborn 
screening, the authors highlighted three important theme areas worthy of further consideration: 1) 
reimbursement for genetic services was found to be particularly burdensome and often lacking; 2) there 
continues to be a need for improved care coordination - the authors suggest that new models should be 
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explored which incorporate different roles and approaches among team members/care providers; and 3) the 
need for more coordinated approaches to education - not just on how to provide effective educational 
resources to families, but also how to ensure that all components of a care team are knowledgeable of the 
different roles and needs of each element of the care process. Overall, the study raises the concern that the 
field is ill equipped to accommodate future growth in NBS conditions, particularly given potential shortages 
in supply of genetic providers. They argue for considering a shift in approach that takes into account where 
the whole health system is moving and how best to incorporate this information within a flexible dynamic of 
care provision (e.g. rethinking how care teams are structured, how medical homes and care coordination 
function for rare conditions).   
Emergency Preparedness in New England 
On April 1, 2011, Dr. Roger Eaton launched New England's first Emergency Preparedness Symposium.  The 
event included 23 participants, with representatives from NBS community labs, state and federal emergency 
preparedness contacts and two consumers. Presenters included Stan Berberich, Hans Andersson, and Bill 
Perry. Participants learned about what worked in other states, identified federal resources that would be 
helpful, and identified a range of action steps to pursue. Recommended steps to pursue included: create a 
regional group to conduct further planning and implementation, identify clear cut protocols, prepare hospitals 
for management of serious cases, improve utilization of electronic records/communication, develop 
formalized agreements, create a website to facilitate communications, develop a useful checklist for families, 
and provide funding to family-to-family health centers to train and strengthen consumer networks. 
Use and Disclosure of Genetic and Newborn Screening Information 
In October 2010, Michelle Winchester completed her work analyzing the many differences in state 
approaches for using and disclosing genetic and newborn screening information for the purposes of 
treatment, a registry, and research. The report provides an overview of relevant guiding policies, addresses 
state variations in the use and disclosure of PHI for quality improvement, registry or research activities, 
documents relevant state laws, and offers a range of considerations for the NEGC to pursue as it seeks to 
improve the coordination and use of information for improved care in the region. 
Collaborations with Regional and National Partners 
This section provides documentation on the affiliations held by NEGC management and collaborative 
council members.  
 
Supporting the National Coordinating Center 
 
The NEGC has representatives in each NCC Work Group:  
 
• Telegenetics Work Group: Rosemarie Smith, MD 
• Emergency Preparedness: Roger Eaton, Ph.D. 
• Long Term Follow-Up Workgroup: Anne Comeau, Ph.D. 
• Evaluation: Peter Antal, Ph.D. 
• Publications: Monica McClain, Ph.D. 
• National Transition Workgroup: Susan Waisbren, Ph.D. 
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• Medical Home Work Group: Carl Cooley, MD 
 
Collaboration with Other Regional and National Groups 
 
• Genetics and Metabolism Psychology Network: Susan Waisbren, Ph.D. 
• National Coalition for Health Professional Education in Genetics (NCHPEG): Leah Burke, MD 
• National Newborn Clearinghouse (Genetic Alliance): Leah Burke, MD 
• National Health Care Transition Center: Susan Waisbren, Ph.D., Carl Cooley, MD 
• Newborn Screening Translational Research Network 
o Clinical Centers Workgroup: John Moeschler, MD, Anne Comeau, Ph.D.  
o Bioethics Workgroup: Anne Comeau, Ph.D. 
o Laboratories Workgroup: Roger Eaton, Ph.D., Anne Comeau, Ph.D. 
o Effective Follow Up Workgroup: Roger Eaton, Ph.D., Anne Comeau, Ph.D. 
o Information Technology Workgroup: Monica McClain, Ph.D. 
• New England Consortium of Metabolic Programs: Susan Waisbren, Ph.D., Leah Burke, MD 
• Next Step:  Susan Waisbren, Ph.D., Carl Cooley, MD 
• Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children 
o LTFU Sub-committee: Carl Cooley, MD, Anne Comeau, Ph.D. 
o Health Information Technology Workgroup: Roger Eaton, Ph.D. 
o Evidence Review: Anne Comeau, Ph.D. 
• Vermont Children’s Health Improvement Program (VCHIP): Leah Burke, MD 
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WORKGROUP ACTIVITY IN YEAR FOUR 
 
This section provides an overview description of each workgroup's activities during Year Four. Material 
presented is drawn from each group's year-end report to the NEGC, with minor edits to improve readability. 
For an across-the-board view of major highlights from each group, please see Appendix E. A record of when 
groups met during the course of the year is provided in Appendix F. 
 
The Quality Improvement Workgroup 
The Quality Improvement (QI) Workgroup has nine members and is led by the NEGC's Principal 
Investigator, John Moeschler, MD. They met three times as a full group between September and November, 
2010. During the project's fourth year, workgroup members focused their efforts on three major areas: 1) 
development of a legal framework that would allow for entry of protected health information into a quality 
improvement registry; 2) creation of web-based software that would house and facilitate development of 
electronic reports of patients involved in participating clinics; and 3) implementation of a quality 
improvement learning collaborative (QILC).  
 
One of the group's first tasks for the year was to establish a legal framework that would enable the utilization 
of patient data across sites. While the group initially pursued creation of a Patient Safety Organization, 
substantive background research and discussions with partners resulted in the group dropping this effort in 
lieu of an approach based on establishing Business Associate Agreements between each participating clinic 
and the hosting data site.   Currently 2 centers have established BAAs under HIPAA with UNH and Global 
Vision Technologies (GVT), with a third center pending. This arrangement allows entry of protected health 
information into the quality improvement registry and enables the cross-site sharing of non-identifiable 
aggregated information for the express purpose of improving patient healthcare processes and, eventually, 
group outcomes.  
 
The second area of work focused on the creation of a web-accessible data-base. GVT developed and 
implemented the NEGC quality improvement data-base, and has provided modifications, as requested. Web 
access has been provided to seven genetics health care professionals (physicians and genetic counselors) at 
two clinical sites. Data for 186 patients have been entered and a first analysis has been accepted by the 
American Society of Human Genetics for an abstract presentation at the annual meeting in October 2011. 
For the third area of work, project staff implemented the first regional learning collaborative to address 
quality of care issues for individuals living with PKU or MCAD5. In addition to a series of planning meetings, 
2 full face to face meetings were held and one support webinar was held. The first session of the QILC 
focused on: introducing participants to the QILC model and discussing some of its strengths and limitations; 
suggested revisions to the PKU and MCAD data collection forms, a review of work flow at each clinic site 
and how the introduction of the new data forms shaped clinic activity, as well as a brief discussion of the 
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patient registry for individuals with developmental delays. The webinar, held in March, offered participants an 
opportunity to begin sharing notes on the implementation process, learned more about the quality 
improvement registry and discussed possible linkages. Lastly, in April 2011, participants again met face to face 
to review some of the collected data and share what was learned. In general, participants agreed that the 
forms were fairly easy to implement on an ongoing basis and several reported unexpected benefits as a result 
of form implementation. These benefits include: 
• helping a clinic to address the multiple issues that they want to address during a patient's visit   
• generating information that is important for care by complementing other care protocols   
• supporting quality care by having critical information in one spot and having access to this 
information over time 
• improving standardization of care 
• helping to see overlap in clinic tasks and seeing each person's role in the transition process. 
 
The Transition Workgroup 
The Transition Workgroup is led by Dr. Susan Waisbren, who is also the leader of the National 
Transition Work Group. The group currently has 18 members. The primary role of the regional Transition 
Work Group is to improve access to transition resources, implement innovative models for transition 
leadership among youth, and to enhance integration of transition practices into the activities of partner 
organizations. The group has solidified due to working together over time in a number of ways. In Year Four 
they developed strong collaborations with the National Health Care Transition Center (NHCTC) in NH and 
Next Step in MA. These innovative partners have been planning their activities and consulting with each 
other in the process of creating a community with shared goals. Specifically, NHCTC, led by Dr. Carl Cooley 
(Chair of the NEGC Medical Home Work Group), began conducting transition Learning Collaboratives and 
launched the Got Transition website. Next Step and Children’s Hospital Boston planned a summer conference 
with expanded outreach for young adults (see details about Face Forward below). Bill Kubicek, Executive 
Director of Next Step and member of the Transition Work Group, sits on the NHCTC Advisory Board. Ann 
Walls and Mallory Cyr, both with NHCTC, joined the Transition Work Group. Ms. Cyr was also a key 
facilitator of Face Forward.  
 
Improving Access to Resources 
At the end of Year Three, the group had produced the Transition Toolkit, including both one page 
educational fact sheets (Metabolic Basics) and the tool itself (Transition Plan). Usage reports at the end of Year 
Four were discouraging in that the tool wasn’t used as much as hoped. The Metabolic Basics, however, were 
viewed quite often and for longer periods, suggesting real and meaningful benefits. Further, a physician in the 
work group shared that he valued the sheets for their portability and regularly advised families to use them. 
The group discussed changing the target audience to providers, who could then steer families to the site. 
 
Developing Young Adult Leaders 
The Transition work group continued to address the need for leadership training for teens with metabolic and 
genetic disorders through Teen Challenge 2010. This three day camp for young people, aged 13-20, was 
designed to build confidence, strengthen bonds, challenge comfort zones and develop some of the skills 
needed to manage complex health conditions. 2010’s Teen Challenge was held July 7th - 9th with nine young 
people in the rural setting of the Friendly Crossways Youth Hostel in Harvard, MA.  
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Another area re-examined by the group was how to engage and empower youth and young adults – an 
essential ingredient in a successful transition. Working with Next Step and modeling their strategies, the work 
group identified functional outcomes (getting a car, going on a date, etc.) rather than health outcomes as meaningful 
motivators. Future efforts may focus more on how to subtly help young adults make the link between being 
healthy and reaching their other goals.  
This focus became the premise for Face Forward Summer Conference for Youth, jointly sponsored 
by Children’s Hospital Boston and Next Step. The conference was held at the start of Year Five, with  
planning underway during Year Four. Other modifications made to heighten the success include: 1) creating a 
youth council to plan the agenda; 2) including young adult facilitators; 3) changing the age range to 16-24; 4) 
stretching it to four days, and 5) including participants with other conditions.  
 
Collaborating with Partners 
Members of the Transition Workgroup are integrated with the New England Consortium of 
Metabolic Programs, regularly touching on transition issues over the course of the year, as well as meeting in 
person at their annual meeting in November 2010.  They help drive transition activities in the Consortium by 
dissemination of information about the Teen Challenge and the tools on the website.  
Since December 2009, the Transition Work Group has been holding joint meetings with the Medical 
Home Work Group chaired by Dr. Carl Cooley.  They met again in person at the NEGC annual meeting in 
December 2010. Dr. Waisbren and Dr. Cooley took initiative by bringing in two young adult presenters who 
helped participants come to a better understanding of the youth perspective in engaging the health care 
system for genetic conditions. They also held a joint conference call in May 2011. Five new members joined 
the Transition Work Group in time for this call: a metabolic specialist, a genetic counselor, a parent, a young 
adult with a genetic condition, and the project director of the NHCTC. The thrust of the call was a robust 
conversation on how to tell if a person has made a successful transition.  Dr. Cooley noted that, other than 
information from adult providers, it is difficult to find evidence of research regarding transition outcomes; 
sharing characteristics of successful transitions may foster resilience in individuals and families.  
Dr. Waisbren also continues to co-chair the National Transition Work Group, which was recently 
given “Work Group” status by the National Coordinating Center in recognition of their efforts and their 
charge. The group holds monthly calls regularly attended by members of the Transition Work Group, 
including the NEGC’s Monica McClain and Karen Smith. There are generally over 12 people on the call, with 
3 or 4 from New England. The primary role of this group is to provide a forum for sharing current transition 
activities across the nation and discussing new directions for the field. Highlights from the discussion during 
the past year include a better understanding of the challenges inherent in developing transition programs 
(especially with locating adult specialists), the need to engage the youth in planning programs, the value of 
including individuals with various conditions as well as separate break-out sessions when developing 
programs, and being honest about what doesn’t work (written transition plans posted on a website rather than 
introduced by a provider). 
 
Medical Home Workgroup  
During Year Four, the Medical Home Workgroup was led by Dr. Carl Cooley. The 16 member group held 2 
formal meetings. 
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In Year Four, the group was initially poised to further test a communication tool among specialists, families, 
and the primary care medical home. This tool, or care plan, had been conceived and developed in previous 
years with the help of Dr. Chris Stille, formerly of UMass Memorial, and with support from the NEGC.  
 
The care plan itself was a one page form in a fillable PDF format. The purpose of the form was to aid 
communications between the parent and doctor concerning what has been done and what concerns and 
requests should be related. Unfortunately, the group concluded at the end of Year Three that although the 
tool itself was deemed useful and user–friendly, it still wasn’t being used in practice settings for a number of 
reasons. One of those reasons, noted by a specialist, was that much of the information was already contained 
in a letter that was routinely sent from her clinic to her patients’ primary physicians. This led Dr. Cooley to 
wonder what other communication methods were already in use.  
 
To explore this question, Dr. Cooley collaborated with the UNH Survey Center to develop the Survey of 
Primary Care Clinicians Regarding the Care of Children with Rare and/or Complex Conditions. The 
goal of this survey was to assess primary care clinicians' comfort, clarity of role, and quality of communication 
in the co-management with specialists of children and youth with rare and/or complex chronic conditions. 
Dr. Cooley defined rare or complex conditions as those that occur in less than .1% of children (rare) or that 
involve two or more body systems (complex) and require on-going medical management of some kind. While 
the conditions are individually uncommon, the aggregate of conditions of this type accounts for 5 - 7% of 
children and youth and includes children who are the highest users of health care services. 
 
The survey was sent to email lists of the NH Pediatrician Society (275) and NH Academy of Family 
Physicians (604). 115 primary care providers responded to the survey. Further analysis of the survey results 
will occur in Year Five. Also in Year Five, Dr. Cooley will conduct a targeted survey/interview of genetic and 
metabolic clinics in New England, looking at the same essential question from that point of view, and 
collaborate with NEGC staff on a national survey of genetic and specialty clinics. Preparation for that work 
was completed in Year Four.  
 
Since December 2009, the Medical Home Work Group has been holding joint meetings with the Transition 
Work Group chaired by Susan Waisbren, PhD. They met again in person at the NEGC annual meeting in 
December 2010. Dr. Cooley and Dr. Waisbren took initiative by bringing in two young adult presenters who 
helped participants come to a better understanding of the youth perspective in engaging the health care 
system for genetic conditions.  
 
The two work groups also held a joint conference call in May 2011. Dr. Cooley provided an update on the 
National Health Care Transition Center (NHCTC), a separate MCHB/HRSA-funded project he has been 
leading since July 2010. He also updated the group on a clinical report, Supporting the Health Care Transition 
From Adolescence to Adulthood in the Medical Home. This report, published in Pediatrics in July, 2011, was prepared 
by the AAP, ACFP and ACP and Dr. Cooley was a lead author. One major component of the NHCTC has 
been to conduct Learning Collaboratives on transition, using to some extent the algorithm for a smooth 
transition outlined in the new clinical report.  
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Dr. Cooley was selected to chair the National Coordinating Center’s (NCC) Medical Home Work Group. 
This committee met in person in January 2011 in Year Four and held monthly conference calls. The primary 
role of this group is to develop a common set of definitions and principles across all seven regional genetics 
collaboratives related to the medical home and the coordination of care among specialists, primary care 
physicians, and families. Highlights of the discussion during the past year include arriving at a common 
understanding of medical home, considering models of care coordination and communications between 
specialists and primary care, and acknowledging the crucial role of families in the process. The workgroup 
intends to produce a white paper related to its deliberations. 
Dissemination, Education, and Marketing Workgroup  
Leah Burke, MD, chairs the Dissemination, Education and Marketing (DEM) Work Group, which currently 
has 12 members.  The group met five times during the year, one of which was in person at the NEGC annual 
meeting in December 2010. 
 
In Year Four the DEM work group continued to work toward completion of an interactive website for 
elementary school teams, a guide for the classroom for children with genetic conditions. This work builds on 
the group’s efforts of the previous two years in which they primarily assessed the need for education about 
genetic conditions among potential audiences and the best way to provide it, and conducted focus groups 
with special educators to vet the project. In Year Four the group focused on 1) working with a web design 
vendor and 2) developing content for the website for the initial five conditions: PKU, Sickle Cell disease, 
Fragile X, Fatty Acid Oxidation Disorders, and 22q Deletion. In Year Five they will pilot, disseminate, and 
expand this new resource for additional conditions. 
 
Working with a vendor to develop the design was a multi-layered process. The goal was to present unfamiliar 
and complex information in a simple manner that was compelling to educators ranging from 
paraprofessionals to specialists. How the information was displayed was as important as the content itself, as 
this impacts whether or not the website will actually be used. The group’s original concept of starting with 
information teachers might find most relevant in the classroom – “challenge areas” (i.e. child has pain, field 
trips, etc.) – and then linking to more in-depth information about genetics, became concrete within the web 
design.  
 
An important task was to finalize the name and URL address with a simple and easy to remember URL to 
increase usage. The group ultimately chose the following name: GEMSS: Genetic Education Materials for 
School Success and www.gemssforschools.org.  They also developed a concept for the logo which will be 
finalized in Year Five.  
 
The DEM work group was fortunate to collaborate with Christine Giummo, Certified Genetic Counselor 
from the University of Vermont, to write content for the website. Ms. Giummo used her expertise to address 
each challenge area for each of the five selected conditions. Challenge areas included:  1) Dietary and Medical 
Needs; 2) Special Education Supports; 3) Behavior/Sensory; 4) Field Trips/Special Functions; 5) 
Absences/Fatigue; 6) Emergencies; 7) Additional Considerations. Ann Dillon, a special education specialist 
from the Institute on Disability at UNH helped to simplify the language. Ms. Giummo also compiled links to 
helpful resources.  
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Focus groups previously vetted the need for the information. The DEM work group also wanted to vet the 
information itself. Toward that end, they identified two condition-specific advocacy groups per condition that 
were willing and able to review the content. Some groups were larger, some smaller; some were regional and 
some were national. One organizational director is a member of the DEM work group, and another is on the 
NEGC Advisory Committee. These new partnerships will strengthen the validity of GEMSS.  
 
In addition to the special education project the DEM group screened an additional resource for the NEGC 
website, the Genetics and Rare Diseases Information Center (GARD). GARD was determined to be not user 
friendly and therefore not recommended for inclusion in the NEGC website.  
 
One final ongoing project, the Newborn Screening Clearinghouse, occurred in conjunction with the Genetic 
Alliance and their collaborative agreement with HRSA. Dr. Burke participated on this Materials Committee 
and the National Advisory Council to recommend resources and represent the needs of our region.  
 
Laboratory Quality Assurance Workgroup 
The New England Newborn Screening Program (NENSP) has developed algorithms to categorize tandem 
mass spectrometry (MSMS) results to better discriminate between false positives and true cases, improve the 
clarity of communications to the medical home, and to better target the use of scarce specialty care resources. 
To be useful for application to regions outside of the NENSP, the universality of these algorithms must be 
proven in a robust manner by application to independent data sets. The project proposed to apply these 
algorithms to data sets independently derived by the newborn screening labs in Connecticut, New York, and 
Wisconsin. During year four, CT informed us that it was unable to continue participation in the project due 
to internal reasons. 
 
In prior years of the project, concentrations of all relevant MSMS markers were collected from CT, MA, NY, 
and WI, for all specimens with out-of-range values for the following markers: C3, C5, C14, C14:1, C14:2, 
C16OH, C18:1OH, C16, C18:1. During year four, analogous data were collected from MA, NY, and WI on 
all remaining markers with relevance for newborn screening (C5OH, C5:1, C5DC, Leu, Cit, and Arg). Drs. 
Sahai and Eaton analyzed these data according to indices and cutoffs developed at UMass. We then compared 
the index-based categorizations to actual follow-up for the following disorders: 3MCC, BKT, GA-I, MSUD, 
CIT-I, ASA.  
 
Some indices could not be applied directly for categorization since some markers utilized in the index were 
not tested by all laboratories. In such cases additional indices were created and cut-offs for these were 
established based on the site-specific population statistics. These markers were C3, Cit, and Arg. The 
categorizations were very effective for most markers but not as useful for one marker in particular. For 
example, markers that showed universal applicability included C16, C18:1, C16OH, C18:1OH, C5, C5:1, 
C5DC, Leu, C14:1, and C14:2. The marker that was less effective was C5:OH. An unexpected finding from 
analysis of the raw data from partner laboratories was that a significant number of specimens had “0” 
concentrations for some markers. In such cases we utilized the “multiples of the mean” (MOM) while 
evaluating profiles and establishing cut-offs. 
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Use of web-based conferences utilizing Acrobat Presenter introduced in Year 3 was utilized for sharing of 
excel and PowerPoint files during web conferencing with all partners.  
 
A summary of findings to date was presented at the Laboratory Subcommittee of the SACHDNC Meeting, in 
May 2011. The New England Newborn Screening Program has already begun accompanying newborn 
screening lab reports with fact sheets to the medical home that reflect the categorizations of this work. It is 
anticipated that other collaborators will make similar use of these indices when the work is completed and 
confirmed. The collaborators plan to submit this work as a detailed publication by the end of the grant 
period, which will make available this approach to screening programs of all states and countries. 
Long Term Follow Up Workgroup 
The Long Term Follow Up (LTFU) Workgroup (NENSP and New England state NBS coordinators) is led 
by Anne Comeau, Ph.D. and has nine members. During Year Four, they continued to focus on issues 
surrounding interstate data sharing and operating principles relevant to our current and future regional LTFU 
system. States continued to make progress in moving forward with both establishing the authority to collect 
LTFU data (MA, ME, RI in particular) and actual data collection (MA and ME and RI).  Work on the 
development of IT systems for protected state-specific LTFU data that are compatible with updates to the 
NENSP core data system has begun. Meetings of “condition” specific NBS workgroups have also continued 
over the course of the year in order to engage specialists caring for infants and children diagnosed with 
newborn screening conditions to develop and refine data collection tools and variables. 
The LTFU Workgoup held a meeting as a part of the 2010 NEGC Annual Meeting in December 2010.  Dr. 
Inderneel Sahai presented LTFU data on children diagnosed with long-chain hydroxyacyl-CoA 
dehydrogenase deficiency (LCHAD) by NBS. LTFU (age range 2-10 years) revealed that while some cases 
remain asymptomatic, others had associated clinical findings such as recurrent biochemical abnormalities, 
mild language delays, muscle pain on exertion, and retinal abnormalities after 3 years of age. This project will 
be formally presented by Dr. Sahai at the upcoming 2011 NBS and Genetic Testing Symposium. In Spring 
2011, under Dr. Sahai’s direction, a second project to evaluate the long term metabolic outcomes of children 
identified with Short chain acyl-CoA dehydrogenase (SCAD) began.  
Dr. Anne Comeau presented Massachusetts data as a part of the CF NBS and Care Quality Improvement 
Short Course at the 2010 24th Annual North American Cystic Fibrosis Conference held in Baltimore, MD 
(October 21-23, 2010). The Massachusetts CF NBS Workgroup began discussions and design of a new LTFU 
project with data collection to begin in late 2011. This project will address outcomes of a subset of patients 
identified by CF NBS over the course of 10 years in order to enhance the development of follow up and best 
practices for this particular subset of children.  
The Hemoglobin Workgroup continued to focus and build upon their LTFU activities. In September 2010, 
the group hosted a successful conference, “Surviving to Thriving: Improving Long-term Outcomes in Sickle 
Cell Disease.” The conference was attended by over 100 people and brought together experts from around 
the county to identify best practices for improvements to patient care. Ms. Claire Hughes of NENSP and Dr. 
Philippa Sprinz of Boston Medical Center also attended the International Public Health Learning 
Collaborative on Hemoglobinopathies meeting held in Atlanta, GA (November 3-4, 2010). This meeting 
focused on the integration of public health and clinical practice as related to hemoglobinopathies. 
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Dr. Anne Comeau continued to represent the LTFU workgroup at national forums including two LTFU sub-
committee meetings of the SACHDNC (January 27-28, 2011 and May 5-6, 2011), the Clinical Centers 
Workgroup Meeting of the NBSTRN (October 14-15, 2010), and at the NBSTRN Effective Follow Up PI’s 
and Partners meeting (March 28-30, 2011).  
Focus on Long Term Psychosocial Follow-Up of Newborn Screening 
In Year Four, Dr. Waisbren collected data on children with the Uniform Screening Method. The Uniform 
Screening Method consists of three instruments to assess development, each of which can be administered by 
non-psychologists (parents) and computer scored and interpreted: 
1. Adaptive Behavior Assessment System-Second Edition (ABAS-II, for infants and adults) 
2. Behavior Rating Inventory of Executive Function (BRIEF, for preschoolers to adults) 
3. Behavior Assessment System for Children-Second Edition (BASC-2, for preschoolers to adults) 
 
Dr. Waisbren gave a presentation on her work in April, 2011, to the International Neuropsychological 
Society. Dr. Waisbren had collected data on 30 cases (MCAD, PKU, and Galactosemia). She included data on 
children who would have been missed for referral, noting that the Adaptive Behavior Assessment System was 
shown to be 94% accurate.  
 
In the process of conducting the work, Dr. Waisbren noted that there were challenges (including insurance 
company coverage for screenings) in getting metabolic clinics to participate. 
 
During Year 5, Dr. Waisbren plans to promote the use of the Uniform Screening Method via the websites of 
the NEGC, the NE Consortium, and the Psychology Network. In the future she will build on her work by 
piloting the Method at two centers, one of which will be Children’s Boston. The goal is to have a “shovel 
ready” vetted instrument that has buy-in from potential users.  
 
Posttraumatic Stress Disorder (PTSD) and Newborn Screening 
Dr. Joanna Fanos' work focused on understanding how best to identify the need for additional supports to 
parents who are notified, post newborn screening, that their child has a serious illness. The need for this 
project centered on the fact that several features of the disorder (re-experiencing, avoidance, numbing 
and hyper-arousal) could impact medical care of the child as well as cause difficulties for the 
family, including well siblings. Dr. Fanos' team conducted an extensive literature review and held multiple 
informational interviews to identify appropriate scales and to develop a recommended protocol following a 
negative outcome for newborn screening. The team recommended use of the Breslau scale6 (a seven item, 
Y/N response questionnaire) as an initial screener for parents. Parents who screen positive on the scale 
should complete either an Adult Self Report Scale7 or an Adult Interview8 in order for a more rigorous 
assessment to be made concerning the need for additional supports. 
                                                           
6 Breslau, N., Peterson, E.L., Kessler, R.C., Schultz, L.R. Short screening scale for DSM-IV posttraumatic stress 
disorder. American Journal of Psychiatry. 1999 156:908-11. 
7 Recommended scales include: Davidson Trauma Scale (DTS), Distressing Events Questionnaire (DEQ), Impact of 
Events Scale-Revised (IES-R), Los Angeles Symptom Checklist (LASC), Modified PTSD Symptom Scale (MPSSSR), 
Penn Inventory for Posttraumatic Stress Disorder (Penn Inventory), Posttraumatic Diagnostic Scale (PDS), PTSD 
Checklist (PCL), Screen for Posttraumatic Stress Symptoms (SPTSS), Trauma Symptom Checklist-40, and Trauma 
Symptom Inventory (TSI). 
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Ethical, Legal and Social Issues 
 
Through its multiple endeavors, the NEGC seeks to address relevant public policy and ethical, legal, and 
social issues (ELSI) affecting individuals with genetic conditions, their families, and health care providers and 
educators. During Year Four, the following areas were addressed: 
Ethical Issues 
Work around the creation of a central data resource to improve understanding of patient services raised many 
discussions around the appropriate use of data for improving health care quality. During Year Four, NEGC 
staff met with a range of national, regional, and state level providers in order to ensure appropriate steps were 
taken to safely manage and appropriately utilize patient information. Additionally, in preparing for its Face 
Forward Summer Conference for Youth, members of the Transition Workgroup took an important step in 
addressing the role of youth participation in program development by creating a youth council that became 
actively involved in planning the event. 
Legal Issues 
Advances in this area continued with the QI workgroup's exploration of forming a patient safety organization 
and subsequent pursuit of BAA agreements among participating clinics as well as LTFU work to solidify an 
agreement with the State of Rhode Island in Year 4 to pursue long term data tracking. The Birth Defect 
Consortium pursued integration of data on birth defects from Maine, Connecticut, Rhode Island, New 
Hampshire, and Vermont. Dr. Eaton's work to launch an Emergency Preparedness Symposium explored 
some of the initial areas to address in developing a regional emergency preparedness plan. Lastly, Michelle 
Winchester completed her work analyzing differences in New England state laws concerning the use of 
protected health information from newborn screening for quality improvement and research purposes9. 
Social Issues 
The NEGC impacted the social context of healthcare for individuals with genetic conditions in a variety of 
ways. Joanna Fanos published her work on the impacts of genomic information on childhood sibling 
relationships. The Birth Defects Consortium outreached to WIC centers in the New England States to 
educate groups about the importance of folic acid. Patricia Rissmiller worked to expand our understanding of 
genetic awareness among minority populations, and Victoria Odesina laid the groundwork for improving 
home health care and quality of life for adults with SCD. Dr. Waisbren created the MCADD Educator’s 
Guide to help teachers better understand the disorder and prevent potential problems from occurring. The 
NEGC supported the development of the National Tay-Sachs and Allied Diseases Association website. 
Lastly, the work of the DEM group to create an online resource for special educators will result in a very 
valuable information resource that will be made available to educators across the nation. 
                                                                                                                                                                                                            
8
 Recommended interviews include: Clinician-Administered PTSD Scale (CAPS), PTSD Symptom Scale–Interview (PSS-I), 
Structured Clinical Interview for the DSM-IV Axis Disorders (SCID PTSD Module), and Structured Interview for PTSD (SI-PTSD) 
9





As a result of LTFU work in Rhode Island, the ability to share LTFU data has now been formally established. 
Along with Massachusetts and Maine, this will continue to have multiple positive impacts on the ability of the 
Newborn screening program to track health outcomes, identify best practices, and ultimately improve the care 
of individuals with genetic conditions. NEGC's support of partner's work, either through letters of support or 
direct funding of innovative grants, led to a range of improvements impacting the policy arena. Support for 
the American Academy of Pediatrics will help to ensure better integration of genetic medicine practices 
among primary care providers. New research was published creating a national profile of children with Down 
syndrome, and Joanna Fanos completed her recommendations for brief and more in-depth mental health 
screens for parents receiving a medical diagnosis for their child. Dr. Sahai published some of the early 
experiences of long term follow up efforts to ensure quality of care of individuals. Lastly, work on Assessing 
Genetic Workforce Capacity continued in Year 4 and resulted in several policy recommendations. 
ELSI issues will continue to be reviewed annually by the NEGC Advisory Council which will advise on 
potential new directions for the collaborative to pursue.  
Evaluation Activities 
During Year Four, the evaluation of the NEGC was led by Peter Antal, Ph.D. Primary roles during the fourth 
year of the collaborative focused on: providing ongoing review of activities, summarizing project activities via 
evaluation reports, promoting coordination with the national evaluation initiative, and conducting the third 
annual stakeholder survey. 
Ongoing Review of Activities 
Peter Antal has actively participated in NEGC meetings, including ongoing planning meetings and meetings 
with the Quality Improvement Learning Collaborative, Collaborative Council, Advisory Council, as well as 
monthly meetings with the principal investigator, project manager, and workgroup chairs. The focus of his 
participation in these meetings is to provide historical context to guide decision making, technical support in 
areas of research, and suggest areas of follow-up by staff. 
Evaluation Reporting 
During the past year, the Year Three Project Report and Year Four Annual Meeting report was posted as was 
the Year Three Stakeholder survey. All reports were provided to staff for review and feedback prior to final 
publication as public documents on the project’s website. Reports include: 
 Results of Stakeholder Survey for Project Year 3: Dec. 2010 
 Annual Evaluation Report for Project Year 3: Dec. 2010 
 Summary of the Year 4 Annual Meeting: Feb. 2011 
 
In addition to the above reports, Dr. Antal also supported HRSA's strategic planning process by conducting a 
survey and a facilitated discussion with other regional collaboratives involved in improving genetic services. 
The summary of recommendations can be found in the document, Strategic Planning Recommendations for 


































Fig. 2 NEGC Evaluation Pageviews




As shown in Figure 2 below, online views of evaluation material peaked in January (27 unique views) and 










Dr. Antal has continued to represent the New England region by monitoring and updating national 
benchmarks for regional genetics programs. Dr. Antal has participated in conference calls and has regularly 
solicited input from NEGC staff on key issues leading to their creation and utilization. Reporting for the 
national benchmarks is based on regional activities between Dec. 1, 2009 and Nov. 30, 2010. Results are 
provided below:  
 Outcome Measure A1: Increase in the percentage of states/territories in the region with 
collaborations facilitated by the Regional Collaborative between primary care providers (PCPs) and 
specialty (including genetic) providers to improve care coordination for people with heritable 
disorders. 
o Result: 100%. All New England states were involved in collaborations facilitated by the RC 
between PCPs and specialty providers. Examples of collaboration include: 
 Education and awareness building regarding medical home occurred through the 
NEGC annual meeting and the New England Consortium of Metabolic Programs 
annual meeting. 
 Collaboration between medical home workgroup and transition work group targeted 
care in both specialty and primary care settings. Dr. Susan Waisbren has used the 
Transition Plan documents with 10-15 patients and has posted these care plans on the 
New England Consortium of Metabolic Programs website. Additional material 
reviewed and posted to the website included: Acute Illness Protocols, Newborn 
Screening Guide for Prenatal Educators, Newborn Screening Prenatal Curriculum, 
Transition to Adult Care guide, Transition Plan, and many others.  
 In Massachusetts, Dr. Waisbren, via NEGC’s innovative projects program, led the 
Personal Transition Health Plan Project at Children’s Hospital Boston. The long-term 
goal of this project was to develop and pilot a practice model that ensured that every 
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adolescent and young adult patient seen at a genetics or metabolic clinic had thought 
about and documented a plan for on-going health care that addressed the specific 
needs of his or her specific condition, with a focus on symptoms that are relevant to 
adults.  
 Dr. Burke attended the annual NCHPEG meeting as the American Academy of 
Pediatrics representative. She presented the data from our focus groups on the special 
educators' tool at that meeting. Dr. Burke reported back to pediatricians and pediatric 
clinical geneticists on the NCHPEG meeting presentations and initiatives. 
 NEGC’s workgroups have begun integrating their efforts (Medical Home, Transition, 
and Quality Improvement).  The medical home pilot project was implemented in 
2010. Key staff (Dr. Carl Cooley, Dr. Chris Stille, Dr. John Moeschler, Dr. Wendy 
Smith) have collaborated with the annual metabolic consortium meeting and have laid 
the foundation for more integrated work with the NEGC. 
 Joanna Fanos’ work on parent perspectives of the diagnostic and follow up process 
helped to identify a series of recommendations that can provide needed supports for 
families dealing with the challenges of a new diagnosis.  
 Dr. John Moeschler has been working with the QI workgroup on developing a 
standard set of quality improvement data points that will be collected by multiple clinic 
sites. Central to this effort is the researching and potential creation of a Patient Safety 
Organization (PSO) and/or data sharing business agreements that will enable the 
sharing of information among providers to aid in quality improvement efforts in the 
region.  
 Dr. Moeschler has collaborated with a planning team to create the initial framework 
and pilot tools for a new Quality Improvement Learning Collaborative serving the 
New England region.  
 Stephanie Miller of Dartmouth Medical School has formed the New England Birth 
Defects Consortium to facilitate project and data collection coordination among New 
England birth defect registry programs. The aim of the consortium is to improve 
services for infants and children with birth defects by promoting regional 
collaboration in surveillance data sharing, birth defects research, prevention activities 
and health care quality improvement. 
 Outcome Measure B1: Increase in the number of genetic services visits and NBS follow-up specialty 
visits provided to individuals/families through distance strategies implemented by the regional 
collaborative. 
o Result: NA.  NEGC did not provide support for service visits through RC implemented 
distance strategies during this period. 
 Outcome Measure C1: Increase in the percentage of states/territories in the region that have received 
current materials or other assistance from the RC on emergency preparedness/contingency planning 
for newborn screening (NBS) and genetic services. 
o Result: 100%.  Departments of Health / NBS programs in each of the states have received a 
New England Newborn Screening Program COOP Plan. Stakeholders were involved in the 
development of an Emergency Preparedness workshop held on April 1, 2011. 
 Outcome Measure D1: Increase in the percentage of states/territories in the region that have 
evaluated and made recommendations on implementing the ACHDNC recommended NBS panel. 
o Result: 100%.  All states in the region have evaluated and made recommendations on 
implementing the ACHDNC recommended NBS panel. Note that this process is independent 
of NEGC activities for the reporting period. Only Massachusetts, Rhode Island, and 
Connecticut have evaluated and made recommendations on SCID. 
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 Outcome Measure E1: Increase in the percentage of states/territories in the region with systems in 
place to track entry of newborns into clinical management for newborns who are diagnosed with 
conditions mandated by their State-sponsored newborn blood spot screening programs. 
o Result: 100%.  All states in the region have systems in place to track entry into clinical 
management for newborns diagnosed with conditions mandated by State-sponsored newborn 
blood spot screening programs. Note that this process is independent of NEGC activities for 
the reporting period. 
 Outcome Measure E2: Increase in the percentage of states/territories in the region with systems in 
place to track entry into clinical management for newborns who are diagnosed with hearing loss 
through their State-sponsored newborn hearing screening programs. 
o Result: 100%.  All states in the region have systems in place to track entry into clinical 
management for newborns who are diagnosed with hearing loss through their State-sponsored 
newborn hearing screening programs. Note that this process is independent of NEGC 
activities for the reporting period. 
 Outcome Measure E3: Increase in the percentage (number) of states/territories in the region with 
systems in place to track receipt of clinical services and/or health outcomes for children who are 
diagnosed with condition(s) mandated by their State-sponsored newborn blood spot screening 
program and/or with hearing loss through their State-sponsored newborn hearing screening 
programs. 
o Result: 17%.  Only Massachusetts meets the criteria of having a long term follow up system 
for all conditions in each area (metabolic, endocrine, hemoglobin, cystic fibrosis, and hearing) 
mandated by the State-sponsored newborn blood spot screening program. States in the region 
provide variable extents of long term follow up tracking for genetic conditions identified by 
NBS. The variety is dependent on the state and the particular condition. 5 of 6 states are 
working with the New England Newborn Screening Program (NENSP), following and 
modifying the model set in Massachusetts to ensure LTFU in a manner that allows quality 
assurance and quality improvements.  
 Outcome Measure F1:  Increase in the percentage of states/territories in the region whose NBS 
programs disseminate “just-in-time/point-of-care” information on specific heritable disorders to 
primary care providers (PCPs).  
o Result: 100%.  All state NBS programs in the region disseminate information on heritable 
disorders to primary care providers. Note that this process is independent of NEGC activities 
for the reporting period. 
 Outcome Measure G1:  Increase in the percentage of Regional Collaboratives that have completed a 
regional genetic services plan. 
o Result: 100%.  NEGC’s plan is outlined in its annual grant application to HRSA. The plan is 
tied to a series of objectives, action steps, timelines, and resources that are followed to carry 
out NEGC’s mission. The goals and strategies adopted by NEGC are reviewed and updated 
annually by the Advisory Council. 
 Outcome Measure G2: Increase in the percentage of Regional Collaboratives that have reviewed 
and/or updated their regional genetic services plan at least every two years. 
o Result: 100%.  The plan is reviewed on an annual basis by the project’s collaborative council, 
advisory board, and stakeholders. Initiatives proposed for 2011 were reviewed during the 
December, 2010 annual meeting of the collaborative. Multiple recommendations were 
provided on next steps for the collaborative during 2011 which the staff will review and 





NEGC Stakeholder Survey for Project Year Four 
For Year Four, the evaluator again worked with project staff to update and implement the NEGC stakeholder 
survey. The survey was administered online between October and November 2011. A summary of the results 
follows. 
SUMMARY OF FINDINGS FROM THE YEAR FOUR STAKEHOLDER SURVEY  
[Executive Summary excerpted from New England Genetics Collaborative, Results of the Partner Survey for Project Year Four 
by Peter Antal, Ph.D. (January, 2012). For the full report, please download from 
http://www.negenetics.org/AboutUs/Evaluation_reports.aspx 
To facilitate feedback from its stakeholders, the NEGC conducts an annual survey to identify concerns, 
document how the project is doing, and solicit suggestions for improvement. One hundred-forty-one email 
invitations were sent out between October and November 2011 to stakeholders of the New England Genetic 
Collaborative (NEGC). Of these, one opted out and 63 provided responses (45% response rate).  
Since the 2009 report, there was improvement in two important areas. When asked whether they had a clear 
understanding of the NEGC's mission, 73% agreed (vs. 60% in 2009). Concerning whether the NEGC had 
made substantive and clear progress in achieving its mission, 72% agreed (vs. 47% in 2009). Feedback on the 
project's evaluation reports was generally positive with 67% to 70% of respondents indicating that each of the 
reports helped them understand the progress and challenges of the initiative (vs. 60% to 75% in 2009).  
Feedback from the Advisory Council was high this year, with 13 members participating. Most participants 
(>75%) felt that there was a good spirit of cooperation, that meetings were well run, that the RCC provided 
excellent support and responded effectively to questions, and that the Advisory Council was achieving its 
main objectives.  
Project recommendations highlight the need for continuing to strengthen communication efforts of the 
NEGC, identifying new collaboration opportunities for members of the Advisory Committee, making 
effective use of potential partner contributions, improving consumer/family representation in regional 
change, pursuing sustainable initiatives, addressing multiple barriers to care for families, and improving access 
to NEGC resources. 
COMPLETION OF OBJECTIVES IN YEAR FOUR 
 
Table 3 provides a complete list of the objectives set forth by project staff at the beginning of the project year 
(with modifications based on changes in the project) as well as the status of each objective as of June, 2011. 
Measures of objective “status” relative to implementation over the course of the 5 year project are defined by 
the following key: 1. Completed as planned, 2. Completed - deviated substantially from plans, 3. In progress - 
satisfactory, 4. In progress - unsatisfactory, 5. Initiation of activity deferred, 6. Activity abandoned, 7. Not 
scheduled to initiate this period, 8. Insufficient documentation available.  Additionally, a review is provided on 
the relative success of the objectives during Project Year Four. Review results are defined as: 
 28 
 Successful (34 of 54): All definitions of success for an objective have been fully met or the results of 
the activity in question fulfill the intent of the measure. 
 Partially Successful (18 of 54): Definitions of success for the year only partially met. Although not 
fully realized, substantive progress has been made in a number of core areas with fulfillment of the 
goal expected by the next project year. 
 Unsuccessful (2 of 54): Although some work on an activity may have been done, primary components 
of an activity targeted for the year were not substantively addressed within the time period. Lack of 
success may be due to a number of factors, including lack of participation by certain groups, delays in 
timeline for other project components, and the need to shift project priorities such that other 
components could be fulfilled in Year Four. 
 
Table 3: Status of Goals and Objectives of the NEGC, Project Year 4 




Yr. 4 Definition of 




supports to the 
NEGC 
3 NEGC meets yearly 
objectives. 
Review: Successful 
All core staff activities completed 
during course of year. 
2 Continue close 
collaboration with 
WG and AC 
3 Work Group and 
Advisory Committee 
members feel supported 
in the work they do and 
have access to the 
resources they need to 
accomplish their goals. 
Review: Successful 
Meetings are held regularly and 
supports provided when requested 
as resources allow. 89% of 
Stakeholder Survey respondents 
from the Advisory Committee 
indicated that the RCC provides 
excellent support. 
3 Develop and 
implement a 
communications and 
outreach plan for the 
NEGC 
3 Stakeholders report 
satisfaction with being 
able to voice their 
opinions and feel that 
they've been heard.  
A majority of 
stakeholders understand 
the NEGC's mission and 
the steps it is taking to 
achieve that mission 
Review: Successful 
A majority (74%) of participants 
at the 2010 annual meeting felt 
they had an opportunity to share 
their perspective.  
73% of respondents of the Year 4 
Stakeholder survey felt that they 
had a clear understanding of 
NEGC's mission and steps it is 
taking to achieve that mission.  
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New groups and 
individuals are 
represented on the 
NEGC stakeholder list. 
Review: Successful 
Between Yrs 3 and 4, participation 
of stakeholders (defined by 
mailing list) increased from 75 to 
140.  
4 Maintain, update and 
enhance NEGC 
website 
3 The NEGC stays current 




Website is maintained and 
updated continuously. 
Stakeholders have 
information necessary to 
keep informed of all 
project developments. 
Review: Successful 
Stakeholders received 3 quarterly 
updates, mid-year report, and an 
annual report describing project 
progress. 
Website is utilized by 
growing numbers of 
individual users. 
Review: Successful 
Starting Nov.2011 with the new 
website, unique users increased 
from 28 to 254. 
5 Implement Special 
Projects  
3 Genetic Workforce study Review: Successful 
Research and analysis completed 
during Year 4 for the New 
England region and 
recommendations provided for 









Group met for the first time on 
May 9, 2011 to identify core issues 
and outline next steps. 
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QUALITY IMPROVEMENT 
No. Objective Status 
Yr. 4 Definition of 
Success 
Yr 4 Results 
1 Registry will be 
implemented for all 
patients with 
developmental delays 
at all 5 sites. 
3 All sites entering 
complete, quality data on 
all patients meeting 
criteria. 
Review: Partially Successful 
2 sites and four medical geneticists 
entering data, 1 site in IRB review,  
340 total patients entered as of 
Dec. 2011. 
Data have been analyzed and 
poster will be presented at 
ASHG/ISHG annual meeting in 
Oct 2011 in Montreal 
2 Create a PSO to host 
data collected from 
clinic sites and/or 
obtain exemption 
letters for each site 
through CPHS 
3 Updated Definition: Legal 
framework in place 
enabling hosting and 
utilization of data from 
participating sites. 
Was: ARHQ website lists 
all approved PSOs / sites 
participate in registry 
under exemptions 
Review: Successful. 
PSO efforts were dropped after 
multiple discussions with national 
and regional partners as it was 
determined that the developments 
of BAA agreements would be a 
better fit for the NEGC's work.  
BAA agreements in place for 2 
sites (and 4 medical geneticists) 
and templates created for IRB 
waivers as not human subjects 
research but quality improvement 
activity. 
 
3 Implement QI report 
structure 
1 Report format in Registry Review: Successful 
The vendor hosting the database, 
GVT, has created and 
implemented the database, with 
revisions added, as needed. 
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4 QI data submitted, 
analyzed and reported 
from all five current 
clinical genetics sites. 
3 Updated Definition: 
Registry in place and 
utilized by all 3 clinical 
sites 
Was: Registry in place and 
utilized by all 5 clinical 
sites 
Review: Partially Successful 
2 sites are submitting data to this 
project; a third is in IRB review. 
No additional sites are being 
considered at this time. 
Data have been analyzed and an 
abstract presentation has been 
accepted by ASHG for Oct. 2011. 
Additional analyses/reports will 
be presented at the QI work 
group meeting in Nov. 2011. 




1 10 metabolic centers will 
send teams of 2-3 
members each to QILC 
(3 meetings during the 
year). 
Review: Partially Successful 
9 centers initially agreed to 
participate in the QILC, 5 centers 
have sent teams to full meetings 
of the QILC. 7 centers have 
provided summary data. Two face 
to face sessions were held during 
the project year: Feb., 2011 and 
April, 2011; a third was held 
October 2011. 
 Support webinars 
between learning sessions 
will support teams 
Review: Successful   
1 webinar held between sessions 
one and two of the QILC. A 
second was be held in June 2011. 
6 Establish quality 
improvement clinical 
process and outcomes 
for patients with 
metabolic disorders 
3 A common set of data 
will be agreed upon. 
Review: Successful   
Data set agreed upon. 
Condition-specific 
measures for at least 7 
metabolic disorders or 
problems will be set 
forth. 
Review: Partially Successful   
Agreed-upon additional specific 
measures set forth for 2 
conditions. 
7 Metabolic quality 
improvement registry 
will be established 
(customization of 
Genetics QI registry). 
3 Registry exists and 
contains all the data 
elements defined by the 
QILC. 
Review: Partially Successful 
Substantive progress made during 
Year 4. Data sheets for PKU and 
MCAD were developed. These 
collection sheets have been 
submitted to GVT for 
implementation into electronically 
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accessible data base in Year 5. 
8 Metabolic centers will 
be members of the 
PSO and/or will 
obtain CPHS 
exemption letters and 
have HIPAA BAAs in 
place. 
3 PSO is in place / letters 
are obtained or 
Membership contracts are 
in place for all 
participating centers 
Review: Partially Successful 
Group decided that no linkage 
would be established at this time. 
Two Centers will be involved in 
QI activities for both Metabolic 
and GDD/ID. Those providers 
will access the Registry by QI 
activity. 
TRANSITION 
No. Objective Status 
Yr. 4 Definition of 
Success 







3 Written list of criteria 
identified. 
Review:  Partially Successful 
Collaborative work with Dr. Cooley 
continued through Year 4 with 
resolution achieved concerning 
whether a medical home was able to 
handle a transition. The next phase 
of the work will be to determine 
indicators of success that a 
transition has "successfully" 
occurred. 





3 Agenda promoted via 
published articles and 
presentations 
Review: Successful 
Publications, presentations, and  
materials related to Transition were 
shared in a range of venues (website, 
conferences, regional and national 
teleconferences). 
3 Create materials 




5 Creation of Fact Sheets 
that list issues for adults 
with these disorders 
written for a lay 
audience. 8 fact sheets 
will be produced in 
Year 4.  
Review: Partially Successful 
Dr. Waisbren continued 
development of 4 fact sheets in Year 
4. The new worksheets are due to be 
released once the new ACMG forms 
are completed and information has 
updated and adapted for a lay 
audience.  
4 Hold conference 
for adults with 




A separate conference for adults 
with metabolic disorders was not 
held in Year 4. Efforts transitioned 
to try and support additional 
learning opportunities for 
youth/young adults. A separate 
grant was secured for a conference 
in January 2012 for adults with 
PKU. 













Review: Partially Successful 
Although staff remain well informed 
of current transition practices and 
actively support their 
implementation, a formal summary 
was not updated in Year 4. 








1 Reviews received by at 
least 3 professional 
staff (dietician, nurse, 
fellow). 
Review: Successful 
Protocol reviewed by Dr. Levy, Fran 
Rohr, and Leah Hecht. It was 
determined that the protocol 
required too many resources to 
implement at this time. 




1 10 patients participate 
at Children’s Hospital.  
Review: Partially Successful 
As a result of piloting the transition 
tool,  it was determined that the 
transition tool would be better 
implemented in a different setting as 
there were too many barriers to 
implementation in the hospital 
setting (fewer than 10 patients had 
participated). The Metabolic Basics 
resource received hundreds of hits 
on the New England Consortium 
website indicating that the resource 
was being accessed in alternative 
ways. 
8 Leadership 
training for teens 
with genetic 
disorders. Program 
1 Leadership training 
takes place.  
Review: Successful 
The Teen Challenge weekend was 
held in July 2010. Nine youths 
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at Teen Challenge 
Weekend 
worked to build confidence, 
strengthen bonds, challenge comfort 
zones and develop some of the skills 
needed to manage complex health 
conditions. 
9. Participate in 






3 Plan developed, ratified 
and implemented by 
QILC planning group 
and expert panel 
Review: Successful 
Dr. Waisbren supported the QILC 
throughout Year 4 by providing 
feedback on project material. 
10. Continue to 
represent 
transition activities 
on LTFU as 
needed. 
3 Improved access to 
assessment for all 
adults with genetic 
conditions in New 
England 
Review: Successful 
Dr. Waisbren continued work on 
the Uniform Screening Method by 
collecting data on 30 cases, 
analyzing and presenting the results. 




being developed at 
the Center for 
Medical Home 
Improvement 




Integration with the NHCTC is 
ongoing. Of note, NHCTC staff 
have been directly integrated into 
the Transition Workgroup. 
MEDICAL HOME 
No. Objective Status 
Yr. 4 Definition of 
Success 
Yr 4 Results 
1 Begin field test of 
the care 
coordination 
project in two 
specialty clinic 
catchment areas 
6 Patients and families 
are recruited into trials 
of the care planning 
tool at Children’s 
Hospital Boston (10 
patients / families) and 
one other metabolic / 
genetics clinic (at least 5 
patient / families). 
Review: Unsuccessful 
After review of some of the barriers 
to implementation of the pilot (the 
previous project lead transitioned to 
a new appointment in another 
region, and some of information for 
the care planning tool was already 
being captured by some 
components of the care model), the 
workgroup decided to abandon this 
effort and pursue a new objective to 
improve care coordination in the 
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region (Obj. 2).  
Process data are 
collected at the 
Children’s Hospital site 
including number of 
plans implemented, 











3 Survey tool designed 
and fielded. 
Review: Successful 
In order to further work in the care 
coordination area the group decided 
to seek clarification of the care 
processes that were in place and 
how they were communicated 
between providers and families as 
well as between providers and 
specialists. A tool was developed 
and fielded for the first survey, with 
analysis and completion of the 
second survey expected in Year 5. 
3 Convene at least 3 
meetings of the 
MHWG during 
Year 4. 
1 Two conference calls 
and one face-to-face 
meeting occur. 
Review: Partially Successful 
Group met two times in Project 
Year Four (December 2010, May 
2011). 
4 Continue to 
integrate meetings 
and work with the 
Transition 
Workgroup 
3 Annual face-to-face 
meeting in December 
2010 is a joint meeting 
of the two work 
groups. 
Review: Successful 
A joint meeting was held December, 
2010 and May, 2011 
DISSEMINATION, EDUCATION AND MARKETING 








3 Current model finalized 
and dissemination plan 
created based on 
recommendations 
Review: Successful 
Substantive work was carried out 
during Year 4 to improve the 




Expansion of modules 
utilized in educational tool 
for special educators. 
Review: Successful 
Multiple modules were researched 
and collaboratively reviewed for 
incorporation. 
Revise tool for 
pediatricians and parents. 
Review: Unsuccessful 
Activity to be reviewed during Year 
5. 
2 Create web portal 
based on tool 
"Children with 
Genetic/Metabolic 
Conditions in the 
Educational 
Setting" 
3 Tool posted on website Review: Partially Successful 
During Year 4 the workgroup 
developed the infrastructure and 
basic schematics for the new 






3 Identification of new 
resources / tools to be 
linked to the NEGC 
website and distributed to 
stakeholders 
Review: Partially Successful 
During Year 4, the group reviewed 
the Genetics and Rare Diseases 
Information Center (GARD), 
determined that is was not user 
friendly and therefore not 
appropriate for inclusion on the 
NEGC website.   
DEMONSTRATE EFFECTIVE COLLABORATIONS 
No. Objective Status 
Yr. 4 Definition of 
Success 
Yr 4 Results 
1 NEGC continues 
to participate in 
national work 
groups 
3 The NEGC is actively 
represented on a national 
level by staff and NEGC 
constituents and 
contributes to the 
improvement and 
coordination of genetic 
services. 
Review: Successful 
Project directors and workgroup 
chairs are involved in one or more 
national groups engaged in 
transforming genetic services. 
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2 Link with affiliated 
programs (LEND 
and AUCD) 
3 MOAs developed with 
participating programs 
identifying methods of 
collaboration. 
 
Review: Partially Successful 
In project Year 4, an innovative 
project has been funded with the 
LEND program.  Staff actively 
sought to integrate NEGC activities 
into the NH LEND program, with 
new collaborations to take place 
during Year 5. 
 
 
3 Represent genetics 
issues to wider 
healthcare system 
3 Additional health care 
fields are educated about 
the needs of individuals 
living with genetic 
conditions. 
Review: Successful 
Presentations made to AMCHP, 
NCHPG, and participation in a 
Genetics Blog. Work initiated to 
better integrate genetic services into 
each New England state's 211 
system.  
Public Health Genetics 
and Genomics is 
integrated into other 
academic course work 
Review: Successful. 
Areas of involvement include:  
administering a course on public 
health genetics, providing support to 
UNH's MPH program, and a 
presentation to AMCHP.  
INNOVATIVE PROJECTS PROGRAM 
No. Objective Status 
Yr. 4 Definition of 
Success 




new micro grants 
to spur consumer 
involvement. 
3 A common process is 
established and 
continuously improved 
for the review, selection 
and monitoring of 
awardees that is agreed to 
by all members of the 
review committee 
Review: Successful 
Monitoring and updating of the 
grant process has been continually 
implemented. 
2 Release, award and 
monitor grantees 
1 Grant Cycle completed. Review: Successful 
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for 2010-11 Grant cycle successfully completed. 
 




(regular grants) / 
brief summaries 
(micro grants) 
1 Poster presentations / 
brief summaries 
developed that represent 
and convey the spirit of 
the innovative projects 
program. 
Review: Successful 
4 Innovative grants were awarded 
Poster presentations created, 
reviewed by management staff and 
Advisory Council. 
4 Confirm award 
amount and issue 
RFP for grant 
cycle 5 
1 RFP issued. Review: Successful 
Grant cycle 5 process was 
implemented. 
ETHICAL, LEGAL, AND SOCIAL ISSUES 
No. Objective Status 
Yr. 4 Definition of 
Success 
Yr 4 Results 
1 Address ELSI 
issues within 
workgroups as 
well as through 
special projects 
3 NEGC appropriately 
integrates ELSI issues 
within its work and 
actively pursues projects 
that improve the field of 
genetics in this area. 
Review: Successful 
Examples: Ethical (review of patient 
data utilization to improve service 
quality, involvement of youth in 
planning activities), Legal 
(establishment of BAA agreements 
to enable the work of the QILC), 
Social (education of groups across 
the New England region on the 
importance of folic acid), Policy 
(addition of Rhode Island to the 
LTFU network).  
2 Discuss ELSI 
issues within the 
RCC network. 
3 Issues raised and 
discussed, NEGC lessons 
learned shared with the 
network 
Review: Successful 
ELSI issues are reviewed on an 
ongoing basis. 
LABORATORY QUALITY ASSURANCE 
No. Objective Status 
Yr. 4 Definition of 
Success 




3 Full participation in 
meetings 
Review: Successful 
Dr. Eaton continues to participate 





national initiatives (eg. NBSTRN, 
SACHDNC). 
2 Request and 
analyze lab-




deviations, etc.) on 
~ total of ~ 
50,000 newborns 






3 Data received and 
reviewed. 
Review: Successful 
Substantive analysis work 
undertaken, with wrap up of analysis 
work to be completed in Year 5.  
. 
3 Analyze the raw 
data submitted, 







elevations in same 
sample, Cit, ASA 
3 Additional analysis tables 
created, new indices 
possibly identified. 
Evaluation of such tables 
may suggest additional 
index possibilities beyond 
the indices currently used 
by the NENSP. 
Review: Successful 
New detailed data tables were 
produced, analysis completed on 
3MCC, BKT, GA-I, MSUD, 
CIT-I, ASA. 





review the data 





data on final 
diagnoses. 
1 Meetings held. Target 
web-ex meetings in Sept., 
Nov., Jan, and face-to-
face meeting in March, 
possible web-ex in May 
Review: Partially Successful 









1 Presentation Review: Successful 
Presentation made in May, 2011. 
LONG TERM FOLLOW-UP 
No. Objective Status 
Yr. 4 Definition of 
Success 




in regional and 
national forums 
3 Full participation in 
meetings 
Review: Successful 
Dr. Comeau continues to participate 
on a number of regional and 
national initiatives (eg. NBSTRN, 
Institute of Medicine, CF/SCID 
conferences). 
2 Continue to 
facilitate stepwise 
implementation of 





3 Continued education of 
state teams (NBS 
Advisory committees) 
about Massachusetts and 
Maine experience with 
implementation. 
Review: Successful 
Primary focus during Year 4 was on 
collaborations with Rhode Island. 
Facilitating Workgroups 
and reports back to state 
teams from work groups 
Review: Successful 
Primary focus during Year 4 was on 
collaborations with Rhode Island. 
Continue to legal counsel 
from each state in the 
discussion of method for 
implementation, which 
may be by Charter or by 
other agreements between 
and among states. 
Review: Successful 
Rhode Island agreed to participate 
in the LTFU process. 
3 Continued Data 
Collection and 
Expansion of Data 
Collection 
Activities 
3 Subcontracts established 
with Maine and Rhode 
Island. 
Review: Successful  
Minimum data set defined. Updated 
based on ongoing review of 
information. Maine and Rhode 
Island contracts in place. 
State specific data 
modules created and 
integrated. 
Review: Partially Successful 
These modules are being created in 
conjunction with a very large data 
system replacement by the NENSP 
(otherwise internally funded). This 
project will not be complete during 
this year, and so full implementation 
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of the LTFU accessibility aspects 
will occur after the grant year is 
completed 
4 Data Analyses and 
Publication of 
Analyses 
3 Data analysis prepared for 
QI at the clinic and 
program levels 
Review: Successful 
Analysis reports provided back to 
Mass. and Maine clinics. Reports run 
on MCAD and VLCAD.  CF clinics 
received reports and inquiries. 
Hemoglobin clinics received reports 
and inquiries. Metabolic clinics 
received reports and inquiries. A 
special report on LCHADD has also 
been presented to Metabolic Clinics 









3 Hgb conference to 
facilitate development of 
best practices. 
Review: Successful 
Hgb conference held in September, 
2010 focused on identifying best 
practices for improvements to 
patient care; attended by over 100 
people from across the country.  
Development of best 
practices by clinical 
workgroups 
Review: Partially Successful. 
In process. None of the workgroups 
have established best practices. Hgb 
would like an organization similar to 
the CF foundation. Data collection 
is based on the CDC’s RUSH 
program. Each group (Hgb, 
Metabolic, CF) is structured 
similarly in that they each have 
clinician advisors. They differ in the 
questions they are trying to address 
or document. 
QUANTITATIVE AND QUALITATIVE EVALUATIONS 
No. Objective Status 
Yr. 4 Definition of 
Success 
Yr 4 Results 
1 Gather data on 
program activities 
and outcomes and 
provide ongoing 
feedback to 
project staff and 
3 Management staff report 
evaluation support has 
been an effective aid in 
decision making and 
program improvement. 
Review: Successful 
Management Staff Review:  
Evaluation and survey data are used 
to inform NEGC activities. 
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funder on project 
progress. 
2 Conduct annual 
stakeholder survey 
1 A majority of stakeholders 
participate in the survey 
process and provide 
recommendations for the 
project's improvement 
Review: Partially Successful 
Although there was a substantive 
increase in the number of 
respondents (42 to 63), the 
participation rate of NEGC 
stakeholders for the Year 4 Survey 
was 45%. Substantive feedback 
received on potential improvements 
and future directions for genetic 
services in the New England region. 
3 Complete semi-
annual and annual 
reports which can 
be used by staff to 
improve project 
outcomes 
3 Reports completed and 
utilized by staff to 
improve project outcomes 
and utilized by 
stakeholders to stay 
informed of project 
progress. 
Review: Successful 
Yr 3 Report and Yr 4 Mid-Yr report 
completed and reviewed by staff.  




3 NEGC is actively 
represented on national 
measurement efforts.  
Review: Successful 
NEGC was represented on all 
meetings and provided information 






OBJECTIVES FOR YEAR FIVE 
 
Table 4 provides a list of objectives to be completed by each of the relevant workgroups and administrative 
teams for Year Five of the NEGC project. The status of each objective will be updated by the Project 
Manager on a monthly basis during meetings with the various Workgroup chairs using the following key: 1. 
Completed as planned, 2. Completed - deviated substantially from plans, 3. In progress - satisfactory, 4. In 
progress - unsatisfactory, 5. Initiation of activity deferred, 6. Activity abandoned, 7. Not scheduled to initiate 
in period. Workgroup chairs have established a series of performance measures to document successful 
achievement of each of their objectives. 
Table 4: Year 5 Goals and Objectives 
Establish and Maintain the NEGC 
No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Continue implementation of 
core administrative supports to 
the NEGC 
NEGC is able to successfully pursue goals 




2 Budget Management Operating expenses for the fiscal year are 
within the budgeted amounts 
Budget analysis of UNH 
records 
3 Continue close collaboration 
with WG and AC 
Work Group and Advisory Council 
members feel supported in the work they 
do and have access to the resources they 
need to accomplish their goals. Meetings 
and conference calls held 
Work Group and Advisory 
Council members feel 
supported in the work they 
do and have access to the 
resources they need to 
accomplish their goals. 
Meeting and call minutes 
4 Annual meeting Meeting held Meeting report 
5 Communications and outreach 
plan 
Stakeholders report satisfaction with being 
able to voice their opinions and feel that 
they've been heard. Consistent increases in 
NEGC web site utilization. 
Stakeholder survey 
responses, quarterly updates 
sent, web site analytics 
6 Implement Special Projects Special Projects achieve stated goals within 




No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Registry will be implemented 
for all patients with 
developmental delays at all 5 
100% of appropriate data sheets entered at 
each of the 5 sites; 
# sheets entered/# eligible 
patients by site; 
 44 
sites. 100% of data sheet 100% completed (i.e., 
no missing data elements) 
# data sheets completed 
correctly/# total sheets by 
site; 
Data sources are: 1) the 
NEGC registry; and, 2) data 
compilation for those sites 
not yet on Registry. 
2 Obtain exemption letters for 
each site through CPHS 
HIPAA BAAs in place at all participating 
centers 
NEGC offices have copies 
of each HIPAA BAA. 
3 Implement QI report structure Standard report form in place and 
functional. 
The standard report 
generated aggregate data for 
all sites in Registry. 
4 Submit for publication white 
paper on process of quality 
improvement in clinical 
genetics services. 
Paper completed Paper completed and posted 
on NEGC site. 
Paper submitted and 
published in Am J Med 
Genet (Part C) in 2009. 
White paper on the 
Metabolic QI LC is in 
process and will be 
completed in year 5.  
Abstract of the MET QI LC 
to be submitted to annual 
SIMD meeting late Fall 
2011. 
5 QI data submitted, analyzed 
and reported from five clinical 
genetics sites.  
Registry reports all centers entering data in 
Registry. 
Data is complete for each site. 
Registry reports total 
numbers of records and data 
entry points by site. 
Registry reports on data 
quality for completeness by 
site 
Five sites participating 
6 Convene one “Breakthrough 
Learning Series” in quality 
improvement for NE 
Metabolic Centers, based on 
the Institute of Healthcare 
Improvement using the 
existing four sites and with the 
Series completed. 
Measures in place to assess implementation 
of quality improvement activity in 8 
metabolic centers 
100% of participating centers will utilize care 
a) X=participating centers; 
Y=centers using checklists; 
Y/X = % participating 
centers active with checklists 
b) # Children with MCAD, 
 45 
purpose of rapid dissemination 
to other NE Centers. One 
face-to-face meeting with 3 
webinars will be completed. 
We will target urban academic 
or private clinical genetics 
practices from Boston, 
Worcester, Providence, New 
Haven, etc. 
checklists  
100% of eligible patients will have completed 
checklists by the end of Collaborative.  
Information is complete for 90% of 
patients identified and enrolled in the clinic 
registry (by end of the collaborative). 
100% checklist completion (number of 
items on the checklist complete/total 









Checklist activity leads to predicted and/or 
unanticipated “tests of change” in the 
practice.  
[“tests of change” are when an 
improvement area is identified, an aim 
written, and change ideas are tried out with 
a few patients, refined, implemented and 
measured (plan, do, study, act (PDSA)] 
cycle.] 
 
Optimal time interval between PKU screen 
positive and PKU diagnostic confirmation. 
Optimal time interval between MCAD 
screen positive and diagnostic 
confirmation. 
Optimal time from confirmation of dx to 
“metabolic control” of PKU. 
Optimal time from MCAD diagnosis and 
PKU, = X; 
# Children with checklists 
completed = Y 
Y/X= % of identified with a 
checklist 
 
# Children with MCAD, 
PKU, others conditions 
identified and enrolled in 
registry = X 
Registry information 
complete = Y 
Y/X = % registry 
information is complete 
 
Score self on checklist for % 
complete (e.g. 25%, 50%, 
75%, 100%) X=number 




# of predicted or not 
predicted tests of change 
(defined by site; require 






# days from birth to 
diagnosis (both PKU, 
MCAD). 




# days from PKU dx to Phe 
level < 6 mg/dL 
 
# days from MCAD 
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patient diet counseling completed 
 
 




No. Objective Yr. 5 Definition of Success Measurement of Success 
1 
Continue to publish, present, 
and disseminate transition 
related agenda  
Agenda promoted via published articles 
and presentations 
Publications, presentations, 
and disseminated materials 
2 
Create materials for youth and 
adults on metabolic disorders 
Creation of Fact Sheets that list issues for 
adults with these disorders written for a lay 
audience. 4 fact sheets will be produced in 
Year 5.  
Distribution of Fact Sheets 
through the internet and 
clinics. 
3 
 Continue to monitor new 
advances in transition 
programs – especially through 
special education initiatives 
Transition practices are summarized for 
genetics and metabolism 
 
Publication of review article 
and/or posting of summary 
to NEGC website. 
4 
Leadership training for teens 
(Face Forward) with genetic 
disorders in collaboration with 
Children’s Hospital and Next 
Step 
Leadership training takes place.  Summary on training  
5 
Participate in effort to improve 
quality in metabolic clinics via 
learning collaborative 
methodology  
Continued participation in QILC, 
incorporation of transition elements into 
QILC activities and recommendations. 
Meeting reports 
6 
Continue to represent 
transition activities on LTFU 
as needed. 
Completion of study to determine validity 
of the Uniform Assessment Method (using 
PKU, UCD’s and Galactosemia as models) 
Publication in a peer 
reviewed journal 
7 
Collaborate with the National 
Transition Resource Center 
being developed at the Center 
for Medical Home 
Improvement 
Seek out new opportunities and 
collaboration 
List of opportunities 
identified and 'next steps' for 
collaboration defined 
Medical Home 
No. Objective Yr. 5 Definition of Success Measurement of Success 
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1 Assessment of PCPs regarding 
care provision for children 
with complex conditions. 
Assessment of current 
methods among genetic and 
metabolic clinics regarding 
communication and 
coordination of care with 
primary care physicians and 
families.  
Survey implemented with response rate of 
15%. Results reviewed and summary report 
generated. 
Evaluator review  
 
 
Telephone interviews conducted with 75% 
of clinic settings. Results reviewed and 
summary report generated. 
Evaluator review 
2 Convene at least 3 meetings of 
the MHWG during Year 5 
Two conference calls and one face-to-face 
meeting occur. 
Meeting agenda and 
attendees document the 
meetings. 
3 Continue to integrate meetings 
and work with the Transition 
Workgroup 
Annual face-to-face meeting in November 
2011 is a joint meeting of the two work 
groups. 
Meeting agenda and 
attendees document the 
meeting. 
4 Assessment of PCPs regarding 
care provision for children 
with complex conditions. 
Survey implemented with response rate of 
15%. Results reviewed and summary report 
generated. 
Evaluator review  
Dissemination, Education, and Marketing 
No. Objective Yr.5 Definition of Success Measurement of Success 
1 Launch GEMSS website 
Continuously improve 
GEMSS resource. 
Website launched Evaluator review. 
Expansion of modules utilized in GEMSS 
for special educators. Targeted conditions 
for Year 5 include: Down syndrome, 
Williams syndrome, Achondroplasia and 
other dwarfing conditions and possibly 
NF1. 
Meeting Minutes 
Gather feedback and recommendations 
from website visitors 
Survey created, 
implemented, results 
analyzed, and followed up 
on. 
2 Disseminate GEMSS website Increasing web hits throughout the year. Google Analytics. 
3 Improve utilization of genetic 
education materials 
Identification of new resources / tools to 
be linked to the NEGC website and 
distributed to stakeholders 
NEGC Website, Weblogs, 
Evaluator Review. 
4 Collaborate with core staff to Increased number of genetic services Number of genetic services 
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enhance 211 linkages for 
genetic services 
posted to each state's 211 system posted to each state's 211 
system 
Effective Collaborations 
No. Objective Yr. 5Definition of Success Measurement of Success 
1 Core staff and collaborative 
council members participate in 
national and regional groups 
Each staff and CC member participate in at 
least one regional or national work group 
Work group rosters 
2 Engage LEND students 
and/or students at genetic 
counseling programs in 
research activities 
Student participation results in  poster or 
abstract development 
Product (poster/abstract)  
3 Presentations/publications at 
regional/national venues 
Additional health care fields are educated 
about the needs of individuals living with 
genetic conditions. Presentations given / 
publications issued 
NEGC Publications / 
Presentations list. # of 
publications in medical 
journals covering issues 
facing genetic services, 
cross-collaborative grants 
submitted with primary care 
providers. 
Innovative Projects 
No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Quarterly reports from PI of 
each project 
Reports received Quarterly and year end 
reports 
2 Release RFPs, select reviewers, 
review applications, notify 
applicants 
Grants awarded # of applications received, # 
of applications funded 
3 Present posters at annual 
meeting 
Posters created and displayed # of posters displayed at 
annual meeting 
Ethical, Legal, and Social Issues 
No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Integrates ELSI issues within 
projects 
ELSI projects completed Publications, activities 
identified in Year End report 
Long Term Follow Up 
No. Objective Yr. 5 Definition of Success Measurement of Success 
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1 Document formal authority 
for LTFU on state-by-state 
basis. 
Legislation, regulations  or interpretations 
of state rules 
NBS coordinators 
2 Develop State Agreements for 
extending centralized database 
to include LTFU variables 
Contract amendments Contracts in place 
3 Data collection and analyses of 
minimum data sets.  
Updates on 70% of patients.  Summary data analysis 
4 Refine dataset variables per 
condition-specific needs 
Variable list updated Meeting Minutes 
5 Participate in Interregional and 
NCC activities 
egular participation in activities. Meeting Minutes, 
presentations 
Psychosocial Follow Up 
No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Validate method using 
historical data to compare 
results of the Uniform 
Assessment System to 
psychological testing results 
Method identifies at least 90% of children 
who are at risk for developmental delay, 
learning disabilities, or emotional problems 
Medical records at 
Children’s Hospital Boston 
2 Finalize method Agreement is reached on a method Members of work group 
3 Develop computerized form A system is up and running by 6 months 
into the 5th year 
A website  
4 Pilot the method in 2 
metabolic centers 
Parents of 10 patients (from a range of 
ages, 6 months to 10 years) will complete 
the Uniform Assessment Method 
Completed forms from 10 
parents 
5 Create a website for the 
Uniform Assessment Battery 
Includes description of the method, 
instructions for completing questionnaires 




No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Continued representation of 
quality control workgroup in 
regional and national forums 
Participation at appropriate meetings Documentation of 
participation at meetings 
2 Analyze applicability of lab- Completion of the task as stated Tables that accurately 
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specific index categorizations 
(developed over past 4 years) 
to follow-up data of the 
remaining disorders (those not 
yet analyzed in first 4 years) 
detectable by MSMS 
represent the positive 
predictive values of all 
categories with all disorders 
3 Analyze applicability of lab-
specific index categorizations 
to follow-up data for those 
new babies detected after 
analyses for those disorders 
which were done during earlier 
phases of the study 
Completion of the task as stated Tables that accurately 
represent the positive 
predictive values of all 
categories with all disorders 
4 Hold regular conference calls 
and face-to-face meetings, as 
appropriate 
Holding of said meetings Documentation of meetings 
5 Publish final findings in peer-
reviewed journal 
Publication Submission and publication  
Evaluation 
No. Objective Yr. 5 Definition of Success Measurement of Success 
1 Gather data on program 
activities and outcomes and 
provide ongoing feedback to 
project staff on project 
progress 
Management staff report evaluation 
support has been an effective aid in 
decision making and program 
improvement. 
Annual review, Meeting 
minutes of review. 
2 Conduct annual stakeholder 
survey 
A majority of stakeholders participate in the 
survey process and provide 
recommendations for the project's 
improvement 
Data collected, More than 
50% of known stakeholders 
participate in the survey 
(documented by Survey 
Monkey), Stakeholder 
Survey report generated and 
published to website. 
3 Complete annual reports 
which can be used by staff to 
improve project outcomes 
Reports completed and utilized by staff to 
improve project outcomes and utilized by 
stakeholders to stay informed of project 
progress. 
Meeting minutes affirming 
utilization of material, 
Stakeholder Survey report 
documenting majority 
agreement that the report is 
a useful resource for 
stakeholders. 
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4 Participate on national 
outcome measurement efforts 
NEGC is actively represented on national 
measurement efforts. 
Performance Measure 
reports are fully completed 
and delivered on time. 
 
PROJECT CHALLENGES AND RECOMMENDATIONS 
 
This section provides an overview of both project-wide and Workgroup level issues identified by Dr. Antal 
along with recommended next steps. Challenges included in this section are drawn from issues raised by 
stakeholders during the course of the project, findings from stakeholder surveys and annual meetings, and/or 
staff review during project meetings. Status updates for each are defined as: 
 Not addressed (0 of 12): no substantive activities have been undertaken 
 In process (3 of 12): activities are under way to address the challenge but have not yet led to 
substantive changes in practice 
 Improving (8 of 12): activities have led to substantial improvements in the challenge area 
 Addressed (1 of 12): the basic nature of the challenge has been successfully addressed by project staff 
 
Since the previous year's report: 
 one item (Implications of Insurance Reform) has been moved from 'new challenge' to 'in process.' 
 one item (Access to Genetic Specialists) has been moved from 'not addressed' to 'in process' 
 one item (Many Stakeholders, Limited Funds) has been moved from 'in process' to 'improving' 
 
Update on Challenges Identified to Date  
 
Status: In Process 
Implications of Insurance Reform for Individuals with Genetic Conditions 
Background: At several points during the last few years, several NEGC partners have noted the significant 
challenges that are created by the lack of coverage for certain services by insurance policies. As health care 
reform continues to be implemented, clarity will be needed as to the implications for the health and well-
being of individuals living with genetic conditions. With greater clarity should come a better sense of what 
actions can be taken to address some of the gaps in the health care system.  
Recent Activity: Starting in Year 5, the NEGC took several steps to begin addressing this area. One, forming 
partnerships with Kay Johnson (a national expert on MCH policy and funding challenges and a speaker in 
health reform conversations) as well as the Catalyst Center (a national center dedicated to improving health 
care coverage and financing for Children and Youth with Special Health Care Needs).  Additionally, through 
its innovative project, the NEGC is supporting the University of Connecticut Health Center's work to assess 
implications of the Affordable Care Act for access to genetic medical services in New England. Lastly, the 
NEGC has recently launched two new groups, the Advocacy group which has taken on this issue broadly, as 
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well as a subgroup focused specifically on ensuring access to medical foods for families and individuals in the 
region. 
Recommendation: Review analysis work conducted by the University of Connecticut Health Center as well as 
discussions and findings from the Advocacy and Medical Foods group. Consult with Kay Johnson and the 
Catalyst Center to help the Advisory Committee and NEGC staff to identify best next steps. 
Access to Genetic Specialists  
Background: One of the challenges identified by the Medical Home workgroup during the first project year is 
the scarcity of physicians with specialty training in genetics. More genetics doctors are leaving the field than 
are entering it. Without other substantive changes in the field, this trend will threaten the NEGC goal of 
improving patient access to quality care.  
Recent Activity: The Medical Home workgroup has begun looking at this issue through an assessment of 
communication lines between families, PCPs, and genetic specialists. The purpose of this work is to assess the 
comfort level and communication preferences of primary care physicians related to caring for children with 
rare conditions including genetic disorders. In combination with their survey work of genetic specialists, the 
workgroup will have the potential to identify strategies for improving lines of communication, thus making 
better use and enhanced dissemination of specialist knowledge across PCPs. Additionally, recent 
developments in Year 5 have led to new partnerships with the NH LEND (Leadership Education in 
Neurodevelopmental and Related Disabilities) program. The improved collaborations with both New 
Hampshire's and Maine's activities in this area has the potential of maintaining and even improving PCP 
access to specialists with genetic research knowledge and training. 
Recommendation: Continue to support activities in these areas.  Concerning the NH LEND partnerships, 
outline a set of strategic goals that should be accomplished each year that meets the needs of both 
organizations. Consider integration of recommendations developed by the Medical Home workgroup 
concerning improvements in collaboration between PCPs, families, and specialists into the NH LEND 
curriculum. 
Availability of Care Management Information for Individuals with Genetic Disorders 
Background: Another challenge for Medical Home practice is that little case management information for 
genetic disorders has been published. If this information was more accessible, it is possible that PCPs could 
perform more elements of patient care (and so help to address the lack of physicians trained in a genetic 
specialty).  During Years Two through Four, substantive efforts were made to educate both regional and 
national level stakeholders about the need for a medical home.  
Recent Activity: The care coordination and transition pilot projects helped to raise awareness of these issues 
and created a set of online materials for use by a variety of stakeholders. The Long Term Follow Up 
workgroup had major successes with the inclusion of Maine and Rhode Island as partners in tracking long 
term follow up data. Lastly, the launching of the new Quality Improvement Learning Collaborative as resulted 
in a long term learning partnership being formed across 8 metabolic centers in the New England region.  
Recommendation: 
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• Continue supporting the Medical Home and Transition workgroup’s efforts to implement the care 
planning and transition tools in a variety of settings. The NEGC should consider gathering a minimal 
level of evaluation information (beyond web entries) to aid in future improvement and expansion of 
the tools.  
• Continue supporting the QI and LTFU efforts to integrate data from a variety of settings so that an 
accurate picture can be created on what does and does not produce successful outcomes among 
individuals with a range of genetic and other health conditions. Re: LTFU, projects such as the 
Hemoglobinapathy conference should be supported as they have great potential to bring together 
LTFU data, leaders from across the nation, and area clinics to develop their thinking around best 
practices and to set the stage for improvements in knowledge for gaining successful health outcomes. 
 
Status: Improving 
Many Stakeholders, Limited Funds 
Background: Partners of the collaborative grappled with the challenge of multiple partners planning to submit 
grant applications in response to the same RFA/PAs. Some of the issues encountered included: how to 
balance sometimes competing interests, when the NEGC (and its fiscal agent, UNH) should take a leadership 
vs. supporting role in a grant application, how to determine what is best for the region, and how partner 
organizations can better balance working toward the NEGC mission while fulfilling their own organizational 
mission. In August of 2009, the collaborative council met and, in the process of discussing the above issues, 
developed a protocol for handling future grant opportunities.  While the protocol is helpful for laying out a 
process for initial discussion when an RFP notice is sent out, finding agreement to everyone’s satisfaction as 
to which entity should lead may not always be achievable.  
Recent Activity: The protocol has been used consistently over the past year to inform partners of emerging 
grant opportunities, hold collaborative discussions around potential projects to pursue and to identify most 
appropriate leads. During Year 4, the NEGC had considered applying for a grant to the Genetic Alliance to 
integrate Family Health History Patient Education Toolkits into a health care setting.. Based on discussion 
with partners from Vermont, it was determined that it was most appropriate for a community health center in 
that state to take the lead on applying for the initiative. However, this group ultimately decided not to apply. 
A review of how this process worked during the past year indicated that this was the most feasible solution. 
Recommendation: Continue to seek out and take advantage of opportunities to collaboratively improve grant 
resources in the region. Review annually with partners the NEGC's approach to this area to determine how 
well it is working and to identify any recommendations for improvement in the process.  
Lack of Specialty Care Providers for Adults  
Background: During Year One, concerns were raised about the ability for youth with genetic conditions who 
were transitioning to adult care to have regular access to a PCP in their adult life.  
Recent Activity: The Transition Workgroup, at both a national and regional level, has continued to support 
access to continuous care among youth. This includes dissemination of the Transition toolkit, leading national 
and regional dialog on Transition, and partnering with the Face Forward program to implement youth 
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directed programs geared towards giving youth the skills sets they need to manage a successful health care 
transition.  
Recommendation:  Efforts in this area should continue to be supported to ensure that as many youth as 
possible find a seamless transition in their care provision from youth to adult health care systems. Parallel to 
this, it may be helpful to conduct a region wide survey every few years to gain an accurate scope of the 
problem (e.g. % of youth ages 19-29 with genetic conditions without access to a PCP) as well as a better 
understanding of the primary barriers for effective care among the members of this group.  
Common Conceptions of People, Roles, and Decision Making Processes 
Background: During Years Two and Three, substantive efforts were made to revise the NEGC website with 
information on project structure, major events and membership, increase email communications and updates, 
provide more accessible meetings, as well as organize monthly calls with workgroup chairs. Despite these 
endeavors (and some improvement since then), results from the Stakeholder Survey and the NEGC annual 
2009 meeting continue to indicate a need for better dissemination of information around the work of the 
NEGC and the roles of each of the workgroups and projects.  
Recent Activity: In Year Four, the NEGC launched a major redesign of its website to make information more 
accessible and regularly implemented quarterly email updates to partners in order to inform them of major 
activities of the NEGC. Additionally, the NEGC focused outreach efforts to genetic counselors as well as 
advocates and family members (through the creation of a new Advocacy Committee). 
Recommendation: As documented by respondents to the participant survey, efforts to communicate the 
NEGC's mission to stakeholders has resulted in improvements in understanding. It is recommended that the 
NEGC continue efforts to update the website on a regular basis, inform partners of evolving national 
priorities, continue with the provision of quarterly updates via email, and facilitating communication at the 
annual meeting. In preparation for any future annual meetings, it would be helpful to allocate 15 to 30 min to 
briefly highlight the year's accomplishments to all meeting participants to better ensure that everyone is on the 
same page in moving forward 
Cross-Fertilization of Ideas, Resources 
Background: Findings from the 2009 annual meeting as well as several individuals from the stakeholder 
survey noted the continued need to reach out to like-minded groups at the national, regional, and state levels. 
During Year Three, new partnerships were formed with the Birth Defects Consortium, Genetic Alliance, and 
area hospitals. As the NEGC continues to grow and promote the health and social well-being of those with 
inherited conditions through collaborations of its partners, it will be critical to sustain existing partnerships 
and identify new ones. 
Recent Activity: Additional outreach during Year Four focused on the Birth Defects Consortium, genetic 
counselors, and advocates. Notably, concerted efforts were made to begin strategic integration of NEGC and 
NH LEND activities.  
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Recommendation: Continue to use the opportunity of the annual meeting, with its range of participants, to 
both review current partnerships and identify needed new ones. Further solidify partnership arrangements 
with NH LEND, and pursue potential partnership ideas identified in the 2011 NEGC Stakeholder survey.  
Geographic Barriers to Meeting 
Background: Continued limitations in use of state funds for travel, as well as multiple national and regional 
meetings pose substantive challenges to holding collaborative meetings. During Years Three and Four, the 
NEGC has increased its use of Webex technology for meetings and has sought to combine meeting events 
with other initiatives whenever possible (e.g. combination of NERGG and NEGC annual meeting).  
Recent Activity: Workgroup leaders continue to make good use of conference calls and technology to support 
their meetings when face to face meetings are not feasible.  These resources continue to provide an effective 
means for members to conduct their work. 
Recommendation: Explore more dedicated spaces and/or equipment among partners to further improve 
web-based (e.g. Webex or similar) technologies. While Webex has been useful in the past, video and audio 
capabilities are sometimes limited for full group meetings and can limit potential participation. 
Quality Data Systems 
The QI, Transition, Medical Home, and LTFU Workgroups have all expressed a need for quality patient data 
systems to inform their work and improve outcomes for individuals with genetic conditions. During Year 
Three, substantive progress was made in laying the foundation for data improvement. This was achieved 
through work by the LTFU Workgroup in Maine supporting integration of LTFU systems, QI initiatives to 
start a learning collaborative, and Medical Home and Transition Workgroup efforts to improve on 
information collected (and how it was used) between patients, PCPs, and specialists.  
Recent Activity: In Year Four, substantive progress was made through the addition of Rhode Island to the 
LTFU partnership, establishment of BAAs with Maine (Vermont is pending) and Dartmouth clinics to track 
data on children with developmental delay, and the launching of the quality improvement learning 
collaborative which will look at quality improvement initiatives for PKU and MCAD. 
Recommendation:  As data collection activities get more fully underway and used for quality improvement 
work, there will be a natural collective interest in sharing findings with broader audiences to ensure broad 
dissemination of useful findings. Given the distinction that IRBs can place on research for the sake of 
evaluation, quality improvement, vs. improving knowledge, it will be important to clarify what the potential 
implications are for IRB reviews and the most appropriate role for each group to take concerning the 
handling and use of protected health information for vulnerable populations. 
Patient Access to Genetics Information.  
Background: Concerns have been raised during the course of the project relative to the ability for patients 
with a genetic condition to access relevant information. During Years Two through Four of the project, 
substantive additions were made to the NEGC website to help fill this gap. Additionally, the DEM 
workgroup began reviewing resources for appropriateness and potential inclusion on the website.  
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Recent Activity: During Year Four, the NEGC launched a new Advocacy workgroup which has established 
access to care and understanding implications of the Affordable Care Act as one of its primary areas of focus. 
In addition, this group will serve as a reviewer of the NEGC website and provide suggestions concerning 
additional material to include that would benefit patients and their families. 
Recommendation:  Continue supports for the Advocacy workgroup and the new Medical Foods sub group 
that begins in Year Five. Additionally, make resources available to complete NEGC efforts to support the 211 
system in New England. Currently, there is a substantive lack of information on genetic services in this 
system. It would be helpful to request relevant service providers to link their information in to this system in 
order for individuals and families to have an additional route of access to critical care and support 
information. 
Tracking Progress of Work Groups   
Background: In Year One, an issue was raised by evaluation staff concerning the flow of information and 
timeliness of material / feedback provided. There have been continued improvements in communication as 
observed via monthly meetings, more timely responses to federal report requests, and openness in discussion 
during collaborative council meetings. The addition of an objective and activity tracking plan in Year Three 
aided oversight and planning of project activities substantially. 
Recent Activity: Monthly chair calls, posting of workgroup minutes to the website, and regular use of the 
NEGC workplan have kept staff well informed of the progress of the NEGC and helped to identify needed 
areas for action. 
Recommendation: To support efforts in this area, it would be helpful to establish a standard set of items to 
include in workgroup minutes. At a minimum, it is recommended that all workgroups should include the 
following information in tracking their meetings: meeting date, participants, major discussion points, barriers 
encountered and solutions identified (if any), next steps and person(s) responsible. Though not always 
possible (given the need for formal approval of minutes), minutes should be posted on the NEGC website 
within two weeks following a meeting.  
Status: Addressed 
Development of Logic Models and Performance Measures for Workgroups   
During Year One, evaluation staff sought to develop a series of additional logic models and measures with 
each of the Workgroups. However, given the status of the project and the need for chairs to focus on the 
start up of the program it was decided by both project management and evaluation staff that such reporting 
went beyond the immediate needs of the project. While information flow improved in Year Two, workgroup 
chairs agreed to an initial set of performance measures for their activities during Years Three and Four. These 
measures were then tied to goals, objectives, and individual activities and used throughout the course of the 
year for program oversight. While there will continue to be refinement of the process in the years ahead, the 
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APPENDIX B: NEGC Grant Applications 
 
Direct Applications 
Grant Name Description Amount 
Natural History of Disorders 
Identifiable by NBS 
Project Yr 4. NIH. Collaborate 
with NYMAC to assess natural 
history of several targeted 
conditions in order to create a 
stronger foundation for improving 
care. 
NOT FUNDED 
Administrative Supplemental Project Yr 3. HRSA; funds for 
legal analysis work and creation of 
the learning collaborative. 
$45,000 FUNDED 
June 2010 
Administrative Supplemental Project Yr 2. HRSA; funds for QI 
data registry and electronic 
medical record pilot 
$75,000 FUNDED 
April 09 
Assess capacity of genetic 
workforce 
Project Yr 2. ACMG; assess 
genetic workforce in light of 




Down Syndrome Surveillance 
 
Project Yr 2. CDC; 4 yr grant for 
$400,000 to study prevalence of 
DS at birth and older ages; 
overview of health across lifespan; 
Bob McGrath, David LaFlamme, 
IOD will collaborate 
NOT FUNDED 
 
Genetics Health Care Quality 
Improvement Project: A Multi-
State Pilot Collaboration 





Dartmouth Translational Research 
Center 
Project Yr 2. Submitted by John 




Galactosemia and Premature 
Ovarian Insufficiency 
 
Project Yr 2. AUCD; 
collaboration with Susan 
Waisbren; submitted Oct 08 
NOT FUNDED 
Letters of Support for Partner Applications 
Grant Name Description Amount 
Genetics in Primary Care Institute Project Yr 4. American Academy 
of Pediatrics. Create a community 
of learners to enhance primary 
care provider ability to provide 
genetic related services, address 
systems and policy supports to 
accelerate provision of genetic 
medicine, assess residency training 
curriculum for genetic medicine. 
Funded. 
Family to Family Health 
Information Center 
Project Year 4. Federation for 
Children with Special Needs. 
Funded. 
NBSTRN Project Year 4. American College 
of Medical Genetics. Build an 
electronic data capture tool for 
long term follow up of children 
identified by newborn screening. 
Letter written supporting need for 
activity. 
Noonan Foundation Project Year 4. Children’s Hospital 
Boston. For follow up meetings of 
the Face Forward Program. 
Not funded. 
The Parent-Child Relationship and 
Newborn Screening: Preserving 
the Ties that Bind 
Project Year 4. Assess whether the 
parent-child relationship is 
disrupted in parents whose infant 
receives an initial out-of-range 
newborn metabolic screening 
result and whether uncertainty 
surrounding the result is 
associated with reduced self-
reported ratings of bonding for 
both mothers and fathers. 
Not funded. 
Clearinghouse of NBS 
Information 
Project Yr 3. The NEGC 
supported an application by the 
Genetic Alliance and NNSGRC.  
Funded. The NEGC received a 
subcontract of $10,000 per year to 
support further collaboration. 
Leah Burke serves on the project 
Advisory Committee 
  
Congenital Conditions Program Project Yr 3. The NEGC 
supported an application by the 
Genetic Alliance and Family 
Voices.  




APPENDIX C: NEGC PRESENTATIONS LIST 
 
* New in Year Four
Sharing Work on Project Activities 
* Region 1 Quality Control Project: Multicenter 
Validation of Algorithms to Improve Communications of 
Positive Newborn Screening Results to the Medical Home.  
Secretary’s Advisory Committee on Heritable 
Disorders in Newborns and Children, Laboratory 
Standards and Procedures Subcommittee Meeting, 
May 2011, Washington, D.C.  
Sahai I, Caggana M, Morrissey M, Rodriguez D, 
Baker, M, Hoffman G, Sommers P, Manning A, 
Eaton R. 
* Joint presentation by five Regional Genetics 
Collaboratives 
Association of Maternal and Child Health 




* LTFU data on children diagnosed with long-chain 
hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) by 
NBS. December, 2010, Portsmouth NH. 
Dr. Inderneel Sahai 
 
* Presentation of Massachusetts data as a part of the CF 
NBS and Care Quality Improvement Short Course. 2010 
24th Annual North American Cystic Fibrosis 
Conference. October 21-23, 2010. Baltimore, MD. 
Dr. Anne Comeau 
 
* A guide for the classroom for children with genetic 
conditions: preliminary needs assessment and development. 
National Coalition for Health Professional 
Education in Genetics Annual Meeting, Sept. 23-
24, 2010; Bethesda, MD. 
Dr. Leah Burke 
 
Update on LTFU activities in New England.  
NCC/RC PU Annual Meeting,  
November 17, 2009, Bethesda, MD.  




• NEGC Work Groups 
• Innovative Projects  
NEGC Annual Meeting 
Dec 2009 
 
Meet Your Neighbor: NEGC 




Poster Session: NEGC 
ACMG Meeting, Tampa, FL 
March 2009 
John Moeschler             
Poster session: NEGC 
NCC/RC Meeting, Bethesda, MD 
January 2009 




• NEGC Work Groups 
• Innovative Projects  
• CSHN Survey Analysis Presentation – Bob 
 McGrath 
NEGC Annual Meeting 
Dec 2008 
 
Long Term Follow up of Newborn Screening Conditions in 





Long Term Follow up of Newborn Screening Conditions in 






Long Term Follow up of Newborn Screening Conditions in 
New England ~ Maine NBS Advisory Committee 
September 2008 
Anne Comeau   
 
Educating Students 
Public Health and Genetics 




Class at UNH Graduate Program: Fundamentals of 
Public Health  
Fall 2008 
Amy Schwartz (co-faculty) 
 
Innovative Project: Patients as Teachers 
Multiple presentations to medical school students  
2007-2009 (2 funding cycles) 
Mark Korson, Tufts University, project PI 
 
Innovative Project: Nurse Educators Incorporate ANA 
Guidelines on Genetics 
Videotaped training module presentations, now 
available online 
2007-2008  
Susan Capasso, St. Vincent’s Academy, project PI 
 
Training Professionals 
* Parents’ role in specialty referrals: views from both sides of 
the exam table. Pediatric Academic Societies Annual 
Meeting, April 28-May 1, 2011, Denver, CO. 
Fischer SH, Cooley WC, Mazor KM, Dworetzky 
B, Stille CJ. 
 
* Poster Session: Parents’ role in specialty referrals: views 
from both sides of the exam table. 
Pediatric Academic Societies Annual Meeting, 
April 28-May 1, 2011, Denver, CO.  
Fischer SH, Cooley WC, Mazor KM, Dworetzky 
B, Stille CJ.  
 
* Poster Session: Notes from the front lines: psychosocial 
follow-up of newborn screening. 
ELSI Congress: Exploring the ELSI Universe, 
April 12-14, 2011, Chapel Hill, NC. 
Fanos JH.  
 
* Neurocognitive Outcomes in PKU. 
South East Regional Genetics Group (SERGG), 
March 31, 2011 
New Orleans, LA (presented via webinar) 
Waisbren, S. 
 
* Poster Session: The adult galactosemic phenotype.  
Society for Inherited Metabolic Disorders Annual 
Meeting, Feb 27-March 2, 2011; Pacific Grove, 
CA. 
Waisbren S.  
 
* “Surviving to Thriving: Improving Long-term Outcomes 
in Sickle Cell Disease.”  New England Conference 
sponsored by the Hemoglobin Workgroup. 
September 16 2010, Boston, MA. 
 
* Poster Session: A guide for the classroom for children with 
genetic conditions: preliminary needs assessment and 
development. 
National Coalition for Health Professional 
Education in Genetics Annual Meeting, Sept. 23-
24, 2010; Bethesda, MD. 
Burke L.  
 
CF: recommendations to increase Newborn Screening 
efficiency.  
7th International Congress, Latin American 
Society of Inborn Errors of Metabolism and 
Neonatal Screening,  
December 7, 2009, Cancun, Mexico 
Anne Comeau 
 
Neurocognitive issues in PKU and Transition to Adult 
Care 





Implementing AAP Developmental Screening Guidelines 
in the Primary Care Medical Home 





DEM work group project: Family Health History 
Awareness 
Multiple presentations during pilot phase to health 
care community in NE, now available online 
2007-2009  
Meagan Krasner  
 
Incorporating Genetics Into the Medical Home 








The Primary Care Medical Home and the Care of 
Children with Metabolic Disorders 




Newborn Screening Molecular Training Workshop 
November 18-24, 2008 
Anne Comeau 
 
Newborn Screening and Genetic Testing Symposium  
November 3-6, 2008 
Anne Comeau 
 
Genetic Health Care Quality Improvement.  
Annual Meeting of the National Newborn Screening 
and Genetics Coordinating Center, Bethesda MD.  
January 7, 2009.  
 John Moeschler 
 
Development of Collaborative Organizations.  
National Coordinating Center of the Newborn 
Screening and Genetics Collaborative meeting. 
Chicago, IL.  
June 5, 2009.  
John Moeschler 
 
Lectures given: Office-Based Evaluation of Children with 
Suspected Genetic or Metabolic Disorders.  
American Academy of Pediatrics Visiting Professor to 
the Georgia Academy of Pediatrics. The Diagnostic 
Evaluation of Children with Autism & Related 
Diagnoses.  
Amelia Island, FL. Host Paul Fernhoff, M.D. and 
Frank Bawyer, M.D., FAAP.  
June 18-19, 2009.  
John Moeschler 
 
Translating clinical guidelines into quality improvement: the New 
England Genetics Cooperative experience. 
American College of Medical Genetics, Annual 
Meeting. Quality Improvement Special Interest Group. 
Marc Williams, M.D., host. Albuquerque, N.M.  
March 24, 2010.  
John Moeschler 
 
Workshop: Genotype-first or phenotype-first? How to balance 
laboratory testing with genetic evaluations. Plenary Presentation: 
“Clinical evaluation of patients with developmental delays, birth 
defects and other potential genetic disorders—why complete 
evaluation should precede genetic testing. 
American College of Medical Genetics, Annual 
Meeting. Ballroom C, Albuquerque Convention Center. 
Robert Saal MD and Yves Lacassie MD, hosts.  




International Conference for Adults and Children 




Transition: Psychosocial Considerations 




Innovative Project:  Sickle Cell Disease Life Skills 
Training to Improve Outcomes 
Multiple presentations to young adults in NE 
2007-2009 
Bill Kubicek, Next Step, project PI 
 
Communication of relative risk for cystic fibrosis following a 
positive newborn screening result. Newborn Screening 
and Genetic Testing Symposium, November 3-6, 
2008, San Antonio, TX 
Hale JE, Parad RB, Dorkin HL, Gerstle r, Lapey A 




Quality measures enhanced by short and long-term follow up 
in a newborn screening program collaborating with multiple 
centers. 
University of Massachusetts Medical 
School/Commonwealth Medicine Conference, 
October 25, 2007, Worcester, MA. 
Hale JE, Parad RB, O’Sullivan BP, Quizon AI, 
Martin T, Yee W, Dorkin HL, Comeau AM. 
 
Quality measures enhanced by short and long-term follow up 
in a newborn screening program collaborating with multiple 
centers.  
21st Annual North American CF Conference 
October 3-5, 2007, Anaheim, CA. 
  Hale JE, Parad RB, O’Sullivan BP, Quizon AI, 





APPENDIX D: NEGC PUBLICATIONS LIST 
 
* New in Year Four 
Peer-Reviewed Journal Articles 
1. * McGrath RJ, Stransky ML, Cooley WC, Moeschler JB. National profile of children with Down 
Syndrome: disease burden, access to care, and family impact. J Pediatr. 2011; in press.    
2. * Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, Phornphutkul C. Congenital 
hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: 
incidence and growth and developmental outcomes. J Pediatr. 2011;158(4):538-42. 
3. * Sahai I, Eaton RB, Hale JE, Mulcahy EA, Comeau AM. Long-term follow-up to ensure quality care 
of individuals diagnosed with newborn screening conditions: early experience in New England. Genet 
Med. 2010;12(12 Suppl):S220-7. 
4. * Hale JE, Parad RB, Dorkin HL, et al. Cystic fibrosis newborn screening: using experience to 
optimize the screening algorithm. J Inherit Metab Dis. 2010;33(Suppl 2):S255-61. 
5. Waisbren, S. Establishing a consortium for the Study of Rare Diseases: The Urea Cycle Disorders 
Consortium. Mol Genet Metab., Feb 2010; 100 (Suppl 1): S97-S105 
6. White DA, Waisbren S, van Spronsen FJ. The psychology and neuropathology of phenylketonuria. 
Mol Genet Metab. 2010;99(Suppl 1):S1-2. 
7. White DA, Waisbren S, van Spronsen FJ. Final commentary: a new chapter. Mol Genet Metab. 
2010;99(Suppl 1):S106-107. 
8. Waisbren S, White DA. Screening for cognitive and social-emotional problems in individuals with 
PKU: tools for use in the metabolic clinic. Mol Genet Metab. 2010;99(Suppl 1):S96-99. 
9. Koch R, Trefz F, Waisbren S. Psychosocial issues and outcomes in maternal PKU. Mol Genet Metab. 
2010;99(Suppl 1):S68-74. 
10. Brumm VL, Bilder D, Waisbren SE. Psychiatric symptoms and disorders in phenylketonuria. Mol 
Genet Metab. 2010;99(Suppl 1):S59-63. 
11. Moeschler JB, Amato RS, Brewster T, et al. Improving genetic health care: a Northern New England 
pilot project addressing the genetic evaluation of the child with developmental delays or intellectual 
disability. Am J Med Genet C Semin Med Genet. Aug 15 2009;151C(3):241-254. 
12. McGrath RJ, Laflamme DJ, Schwartz AP, Stransky M, Moeschler JB. Access to genetic counseling 
for children with autism, Down syndrome, and intellectual disabilities. Pediatrics. Dec 
2009;124(Suppl 4):S443-449. 
13. Homer CJ, Cooley WC, Strickland B. Medical home 2009: what it is, where we were, and where we 
are today. Pediatr Ann. Sep 2009;38(9):483-490. 
14. Cooley WC, McAllister JW, Sherrieb K, Kuhlthau K. Improved outcomes associated with medical 
home implementation in pediatric primary care. Pediatrics. Jul 2009;124(1):358-364. 
  
15. Waisbren SE, Levy HL, Noble M, et al. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an 
examination of the medical and neurodevelopmental characteristics of 14 cases identified through 
newborn screening or clinical symptoms. Mol Genet Metab. Sep-Oct 2008;95(1-2):39-45. 
16. Waisbren SE. Expanded newborn screening: information and resources for the family physician. Am 
Fam Physician. Apr 1 2008;77(7):987-994. 
17. Prosser LA, Ladapo JA, Rusinak D, Waisbren SE. Parental tolerance of false-positive newborn 
screening results. Arch Pediatr Adolesc Med. Sep 2008;162(9):870-876. 
18. Hsu HW, Zytkovicz TH, Comeau AM, et al. Spectrum of medium-chain acyl-CoA dehydrogenase 
deficiency detected by newborn screening. Pediatrics. May 2008;121(5):e1108-1114. 
19. Anastasoaie V, Kurzius L, Forbes P, Waisbren S. Stability of blood phenylalanine levels and IQ in 
children with phenylketonuria. Mol Genet Metab. Sep-Oct 2008;95(1-2):17-20. 
Chapters 
* Fanos JH, Wiener L, Brennan T. Potential impact of genomic information on childhood sibling 
relationships. In: Handbook of genomics and the family, Issues in clinical child psychology, K.P. 
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